VECTOR-BORNE DISEASES IN COLONY STRAY CATS OF MILAN CITY by A. DELLA PEPA
1 
 
 
 
 
Università degli Studi di Milano 
 
GRADUATE SCHOOL OF VETERINARY SCIENCES 
FOR ANIMAL HEALTH AND FOOD SAFETY 
Director Prof. Bontempo Valentino 
Doctoral Program in Veterinary Clinical Sciences 
 
 
Academic Year: 2011-2012 
 
 
 
 
 
 
 
 
 
Vector-borne diseases in colony stray cats of Milan 
city 
 
 
 
 
 
 
 
 
                                               Della Pepa Alessandra 
 
 
 
 
 
               Tutor:                      Coordinator: 
 
  Prof. Proverbio Daniela                 Prof. Fausto Cremonesi 
 
             Correlator 
     
         Dott. Eva Spada
2 
 
1 
 
Index 
 
 
Index 
1. Foreword 
1.1 Feline vector-borne diseases 
1.2 Diagnosis of vector-borne diseases 
1.3 Bartonellosis 
1.4 Ehrlichiosis 
1.5 Rickettsial infections 
1.6 Coxiellosis 
1.7 Yersiniosis 
1.8 Tularaemia 
1.9 Borreliosis 
1.10 Anaplasmosis  
1.11 Mycoplasmosis 
1.12 Cytauxzoonosis 
1.13 Babesiosis 
1.14 Leishmaniosis 
1.15 Hepatozoonosis 
1.16 Strategies for control 
 
2. Colony stray cats of Milan 
 
3. Serological and molecular evaluation of Leishmania infantum 
infection in stray cats in a non-endemic area in northern Italy. 
 
 
2 
 
4. Molecular study of vector-borne infections in colony stray cats in 
northern Italy. 
 
5. Attachment 1: Scientific Publications on National Journals and 
Proceedings of  National Conferences 
6. Attachment 2: Scientific Publications on International Journals 
3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreword 
 
 
 
 
CHAPTER 1 
4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
1. FOREWORD 
Vector-borne diseases are caused by a wide range of infectious agents including 
viruses, bacteria, and parasites (protozoa and helminths), which are transmitted 
by a variety of arthropod vectors such as ticks, Diptera (mosquitoes, 
phlebotomine sand flies, muscid flies), lice and fleas. 
Vector-borne pathogens or diseases are important because: 
• they may be highly pathogenic in dogs and cats 
• their transmission is often unpredictable 
• their diagnosis and control are difficult 
• variable clinical signs can develop after long incubation periods and these are 
rarely pathognomonic 
• animals may have persistent infections and thus act as reservoirs 
• several are important zoonoses, such as leishmaniosis, borreliosis, rickettsiosis, 
bartonellosis and dirofilariosis (ESCCAP). 
A wide range of factors may affect the occurrence and spread of VBDs (Otranto 
et al.2009), : climatic and ecological changes, national regulations on the 
management of stray dogs and cats together with the relatively unimpeded 
movement of companion animals to and from countries with a high prevalence 
of arthropod-transmitted diseases has introduced and promoted the diffusion 
both the arthropods and the diseases they carry in previously non-endemic areas 
(ESCCAP, Shaw et al., 2001). 
Another important feature of these diseases is their increasing occurrence in 
wildlife, which act as reservoirs. (ESCCP) Free-roaming dogs and cats are often 
present in urban and rural areas representing a public health concern (Otrantoet 
al. 2010) in many countries of the world: these animals may be at high risk of 
acquiring vector-borne pathogens, mainly because they are often untreated 
against ectoparasites, thus, representing an easy feeding source for them. In 
addition, the general conditions of these animals (e.g., poor nutrition) may 
contribute to susceptibility to some VBDs; likewise, when infected, free-roaming 
cats and dogs are often neither monitored nor treated against vector-borne 
pathogens (Otranto et al. 2010) so they can be an easy source of infection for 
domestic cats who have free access to the external environment.  Effective 
control of vector-borne diseases requires a thorough knowledge of the infectious 
agents, their vectors and major hosts (ESCCAP). 
 
1.1. FELINE VECTOR-BORNE DISEASES 
The arthropod parasites most commonly recognised as vectors of feline diseases 
are fleas of the family Pulicidae and ticks of the family Ixodidae. The potential of 
fly, mite or lice species for disease transmission in cats has not been determined 
(Tabar et al., 2008). However, there are some reported cases of feline 
leishmaniosis in the veterinary literature, which probably means that sandflies are 
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also important vectors of disease in cats (Hervas et al., 1999; Leiva et al. 2005). 
Ctenocephalides felis, the cat flea, is the predominant species of flea found on 
cats throughout the world and is recognised as a transmission vector for 
Bartonella henselae infection, yersiniosis, coxiellosis and several rickettsial 
diseases. Ct felis has also been anecdotally incriminated in the transmission of 
Mycoplasma haemofelis (Haemobartonella felis) although arthropod 
transmission has never been confirmed. Adult Ct felis are obligate, 
haemophagous ectoparasites that spend several months feeding in the stable 
environment on the skin surface of a single cat; the length of time being 
dependent on host grooming (Rust 1994). A percentage (2–15%) of Ct felis, 
particularly males, may move from one cat to another. The intermediate stages 
of Ct felis do not develop on their host, but rather in close proximity to its 
resting place (Kern et al 1992). During these stages, Ct felis is more tolerant of 
temperature and humidity extremes than other flea species. With their serrated 
mouth parts, adult Ct felis produce cutaneous micro-wounds from which they 
feed. Disease transmission occurs through contamination of micro-wounds with 
flea saliva and/or feces, the latter being produced in voluminous quantities at the 
time of feeding (Silverman et al., 1994). The domestic habitats in which most pet 
cats live provide optimal environmental requirements for Ct felis development. 
The free-roaming, hunting behavior of cats encourages exchange between 
domestic and potentially infected sylvatic flea populations, an important factor in 
the ecology of several emerging or re-emerging zoonotic diseases (Azad et al., 
1997;, Shaws et al., 2001). There is limited information on the species of ticks 
capable of attaching to and transmitting infectious diseases to cats. The cats 
seem to be less predisposed to tick-transmitted diseases than dogs. They are 
likely to have innate resistance or adaptation to infection, limiting the disease 
development or impairing the tick-to-cat transmission of the infective agents 
(Shaw et al., 2001). In the cool temperate areas of the northern Europe, the most 
common species found attached to cats are Ixodes hexagonus (the hedgehog 
tick), I. ricinus, I. canisuga and I. ventalloi (Hillyard, 1996, Ogden et al., 2000). I 
hexagonus was found to be the most common tick infesting cats in some surveys 
in the UK and France (Pichot et al., 1997, Ogden et al., 2000). In warmer 
regions, cats have been found infested with Dermacentor spp, Rhipicephalus 
sanguineus and Haemaphysalis spp. (Shaw et al., 2001). 
Arthropod-transmitted pathogens are often associated with the induction of 
immunological abnormalities. Animals that are unable to mount a protective 
immune response may develop persistent sub-clinical infection which 
recrudesces with stress or concurrent disease. Chronic antigen exposure may 
result in exuberant non-protective antibody responses and the induction of 
polysystemic immune-mediated disease. The role of arthropod-transmitted 
diseases in chronic, relapsing syndromes with fever and signs of immune-
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mediated disease in cats deserves further investigation (Shaw et al. 2001). Even 
though the infectious organisms discussed here are dealt with as individual 
causative agents of arthropod-borne disease, there is potential for co-infection to 
occur. Multiple infections can occur when several arthropod species and a 
susceptible host share the same biohabitat. Similarly, multiple species and 
multiple genotypes of the same pathogenic species can occur in an individual 
animal (Shaw et al., 2001). The same arthropod species may be a vector for 
several pathogens and co-infection of individual ticks can occur (Schouls et al., 
1999). Co-infection may partially explain variations in classic clinical 
presentation, pathogenicity and response to therapy, and the role of active co-
infection rather than sequential exposure, can now be clarified by polymerase 
chain reaction (PCR) analysis (Kordick et al., 1999b). 
 
1.2. DIAGNOSIS OF VECTOR-BORNE DISEASES 
Although history and clinical signs may suggest one of the arthropod-transmitted 
infectious diseases, diagnosis should be supported by laboratory techniques 
which include combinations of direct microscopic visualisation or 
immunodetection of infective organisms in blood or infected tissue, microbial 
culture, serological testing, immunoblotting, and PCR (Shaw et al., 2001). In 
endemic areas and in acute disease, direct visualisation (using the light 
microscope) of pathogen agent in Giemsa stained blood smears and in lymph 
node, bone marrow aspirates or skin biopsies is valuable. However, in chronic 
disease, low-grade exposure or subclinical infection, levels of 
bacteraemia/parasitaemia may be low and direct visualisation does not allow 
intra-species differentiation (Shaw et al., 2001). The use of direct 
immunohistochemical or immunocytochemical methods on biopsy samples and 
cytological preparations from infected animals may increase both sensitivity and 
specificity but these techniques are currently only available from research 
laboratories (Shaw et al., 2001). Although culture is still considered the definitive 
test for the presence of infection, there are considerable challenges associated 
with culture of arthropod-borne organisms which limit its availability as a 
diagnostic method in practice (Shaw et al., 2001). As a group, these organisms 
are often fastidious and may require long periods of culture, special media 
(Bartonella, Borrelia, Francisella) or eukaryotic cell co-culture systems 
(Rickettsia, Ehrlichia, Leishmania, Babesia). In addition, the collection and 
transport of material for culture may represent a considerable zoonotic hazard 
(Shaw et al., 2001). Microbiological laboratories should be consulted prior to 
sample submission and sample package and transport should fulfil all biosafety 
requirements. Serological testing is the most practical and commonly employed 
diagnostic methodology for arthropod-borne infectious diseases, and the indirect 
fluorescent antibody (IFA) and enzyme-linked immunosorbent assay (ELISA) 
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tests are most widely used. However, serological testing in cats is severely limited 
by poor availability of feline-specific test kits, in addition to the more general 
disadvantages of reduced ability to identify acute infection, difficulty in 
differentiating infection from prior exposure or vaccinal titres, and antigenic 
cross-reactivity between organisms. A rise in immunoglobulin G titre is required 
to confirm active infection and there is considerable inter-laboratory variation in 
interpretation of significant titres. Serological testing can be supported by 
western immunoblotting to characterise and distinguish the different species 
involved in disease, but immunoblotting has limited availability in practice. Many 
of the problems of serological diagnosis are circumvented by the use of the PCR, 
and methods employing PCR have been reported for most of the arthropod-
borne infections affecting cats. Advantages of PCR include its sensitivity and 
specificity, particularly in the early phases of disease, and its versatility. It can be 
applied to blood, bone marrow, splenic and lymph node aspirates, body fluids 
such as joint and cerebrospinal fluid and formalin fixed tissue biopsy samples. 
Small diagnostic samples can be screened for several pathogens simultaneously 
and PCR can be used to monitor the progress of therapy. However, the 
sensitivity of PCR produces its own problems in interpretation. The presence of 
microbial DNA although indicative of current infection, is not diagnostic for 
disease unless it is present with compatible clinical signs. The use of quantitative 
PCR may well help to solve this problem in the future (Shaw et al., 2001). 
 
1.3. BARTONELLOSIS  
Bartonellosis is caused by fastidious, Gram- negative, intraerythrocytic, 
arthropod-transmitted bacteria of the genus, Bartonella. Several species have 
been identified in wild and domestic cats: Bartonella henselae, B koehlerae, B 
clarridgeiae and ‘B weissii’ although B henselae is themost prevalent and 
geographically widespread (Breitschwerdt et al., 2000).  Asymptomatic infection 
with B henselae or B clarridgeiae is common in cats, which are therefore 
considered to be a major reservoir for human infection. In humans, B henselae 
and B clarridgeiae have been shown to be the agents of the common, but usually 
self-limiting cat scratch disease (CSD) (Kordick et al., 1997, 1999a). B henselae 
has been associated with more profound human syndromes such as the 
vasculoproliferative disorders bacillary angiomatosis and peliosis hepatis, as well 
as endocarditis, prolonged bacteraemia and various ocular disorders including 
Perinaud oculoglandular syndrome, neuroretinitis and chorioretinitis 
(Cunningham et al., 2000). Bartonella are haemotrophic bacteria which are 
facultative intracellular parasites of red blood cells and endothelial cells. They 
can be detected in samples of cat blood as well as in specimens from claws and 
in saliva (ESCCAP). The major vector of B henselae in cats is the flea, Ct felis 
(Chomel et al., 1996). B henselae can be visualised in and cultured from Ct felis 
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for up to 9 days after an infected blood meal (Higgins et al., 1996a); however the 
role of the cat flea as a biological vector has not been fully determined (Shaw et 
al., 2001). Crucial for an infection is both the contact with fleas and their faeces. 
The agent can survive and remain infectious for up to nine days in the faeces of 
infected fleas (ESCCAP). Cat-to-cat transmission of B henselae occurs via 
intradermal inoculation of infected faeces from Ct felis (Flexman et al., 1995, 
Foil et al., 1998). However, the role of the cat flea in the transmission of B 
henselae from cats to humans has not been proven (Shaw et al., 2001). For the 
infection of humans, scratches and bites from cats play a crucial role. It is 
assumed that the oral cavity and the claws of infected cats are contaminated with 
bacteria-containing flea faeces during grooming and that the agent is transmitted 
to humans through skin wounds. Another possibility is the iatrogenic 
transmission in blood transfusions (ESCCAP). The agent B. henselae as well as 
the primary vector Ctenocephalides felis are distributed worldwide. The highest 
probability of becoming infected with Bartonella has been associated with cats 
less than two years of age, cats with access to outdoor areas, stray cats and 
animals in multi-cat households (ESCCAP). There is no breed or gender 
predisposition (Kordick et al., 1999c).  Although geographic environments with 
warm temperatures and high humidity are reportedly associated with the highest 
exposure rates (Breitschwerdt et al.,  & Kordick, 2000), the prevalence in cool 
temperate climates is also relatively high; probably because in colder countries, 
animals are kept in heated domestic or confined environments, facilitating the 
maintenance of the flea life cycle (Shaw). Disease association with naturally 
occurring Bartonella infection is difficult to determine because of its high 
prevalence in apparently asymptomatic cats. Clinical disease is characterized by 
fever, lethargy, transient anaemia, lymphadenomegaly, neurological dysfunction 
or reproductive failure has been reported following experimental infections with 
B henselae and B clarridgeiae (Shaw et al., 2001). However there are limited 
reports of clinical disease in naturally infected cats. There is a statistical 
correlation between cats naturally infected with B henselae infection, stomatitis 
and urinary tract disease (Glaus et al.,  1997). Uveitis associated with intraocular 
Bartonella DNA and ocular IgG production has also been reported in cats 
(Lappin et al.,  1999, Lappin et al., 2000). Uveitis associated with intraocular 
Bartonella DNA and ocular IgG production has also been reported in cats 
(Lappin et al,  1999, Lappin et al., 2000). Pathological abnormalities documented 
in experimentally infected cats have included lymphocytic-plasmacytic 
myocarditis, lymphocytic cholangiohepatitis, lymphocytic interstitial nephritis 
and lymph node and splenic hyperplasia (Guptill et al., 1997). The effect of co-
infection with FIV and B henselae has been investigated and there is no direct 
association between FIV and B henselae seropositivity. However, in cats which 
have serological evidence of both infections, there is an increased risk of 
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lymphadenopathy and gingivitis (Ueno et al., 1996). The diagnosis of Bartonella 
infection is best made by culture and/or PCR because of the high prevalence of 
seropositivity in normal cats. The association of infection and clinical disease is 
difficult to confirm and requires identification of Bartonella organisms within 
tissues such as lymph node showing compatible pathology (Shaw et al., 2001). 
The following diagnostic procedure is recommended: 
1. The presence of clinical signs that may be associated with bartonellosis. 
2. Exclusion of other causes that might explain the clinical picture. 
3. Laboratory tests:  
a. The gold standard for the diagnosis of bartonellosis is blood culture. It is also 
possible to detect Bartonella DNA in samples of blood, tissue, cerebrospinal 
fluid or aqueous humor by PCR. 
b. Antibodies can be detected serologically from approx. 10 to 14 days after 
infection. A positive serological finding only shows that the cat or dog has 
already had contact with Bartonella spp. For the diagnosis of clinical 
bartonellosis repeated testing of serum samples should show a rising antibody 
titre. 
4. Response to treatment with an antibiotic effective against Bartonella spp. 
However, this may be complicated by the fact that the drugs effective against 
Bartonella spp. are broad spectrum antibiotics which are also effective against 
other possible infections which may have been included in the differential 
diagnosis. Despite following this procedure, a definitive diagnosis of 
bartonellosis is not always possible (ESCCAP). 
Treatment of bartonellosis and elimination of bacteraemia is problematic. 
Doxycycline, amoxicillin, amoxicillin/clavulanate used at higher than 
recommended dose rates have been successful in suppressing bacteraemia in 
experimental infections. Rifampicin and enrofloxacin are also reportedly 
effective (Regnery et al., 1996, Greene et al., 1996, Kordick et al., 1997). 
However, total elimination of infection may be impossible despite the use of 
combination therapy such as rifampicin and doxycycline, and prolonged duration 
(4–6 weeks) of therapy. In addition, the risk of re-exposure is high (Shaw et al., 
2001). Even though the mechanism of transmission of Bartonella infection from 
cats to humans has not been determined, the prevalence of Bartonella 
bacteraemia in cats and the risk of Bartonella associated disease in pet owners, is 
decreased by a vigorous integrated flea control program. When uninfected cats 
are housed with B henselae bacteraemic SPF cats in an ectoparasite-free 
environment, there is no evidence of Bartonella transmission between cats 
(Chomel et al., 1996). Furthermore, when continuous preventative treatment for 
fleas and ticks was given to two cats and one dog persistently infected with 
Bartonella species in a single household, the in-contact humans remained 
serologically negative (Kordick  et al., 1998). 
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Authors Year  Journal  Number 
of tested 
cats  
Characteristics of 
feline population  
Methods  Location  Prevalence 
EUROPE        
SPAIN        
Laia Solano-
Gallego et al 
2006 Veterinary 
Microbiology 
118 (2006) 
274–277 
168  IFA+ PCR northeastern 
Spain 
IFAT: 71.4%; 
PCR: 7/168 (4,2%)  
M D Tabar et 
al 
2008 Veterinary 
Parasitology 
151 (2008) 
332–336 
100 cast PCR Barcelona area; 
Spain 
B. clarridgeiae 1% 
Tania Ayllo´n et 
al 
 
2012 
 
VECTOR-
BORNE AND 
ZOONOTIC 
DISEASES 
Volume 12, 
Number 2, 
2012 
 
680 
 
680 (539 (79.3% of 
total) client-owned cats 
; 141 (20.7% of total) 
stray cats were enrolled 
at five humane societies 
in the Madrid 
area) 
 
IFA (1: 64)+ 
PCR 
 
Madrid, Spain. 
 
IFAT: B henselae stray cats 
24.1% (n = 31); client-owned 
cats 23.7% (n = 128). All cats in 
162/680  23.8%. 
PCR: Bartonella spp. DNA was 
amplified and sequenced from 2 
(0.3%): one from a client-
owned cat and the 
other from a stray cat. B. 
henselae DNA from one cat 
(0.15%), and B. clarridgeiae 
DNA from another cat (0.15%) 
 
PORTUGAL        
A. S. Alves et al 
 
2009 
 
Journal 
Compilation 
2009 European 
Society of 
Clinical 
Microbiology 
51 
 
Fifty-one cats 
(domestic, shelter and 
stray) from Lisbon and 
E´vora 
 
PCR 
 
PORTUGAL 
 
35/51 (67.7%); The prevalence 
of Bartonella bacteraemia is 
higher in shelter (76.9%) than 
in domestic cats 
(68.2%) and all stray cats tested 
(n = 2) were 
12 
 
and Infectious 
Diseases, CMI, 
15 (Suppl. 2), 
1–3 
 
positive. 
 
IRLANDA        
F Juvet et al 2010 Journal of 
Feline 
Medicine and 
Surgery (2010) 
12, 476e482 
116 whole 
blood; 83 
serum 
samples 
41 client-owned and 
75  stray cats 
PCR+ELISA IRLANDA PCR: B henselae alone 3 
(2.6%), 3 (4%); B clarridgeiae 
alone 1 (0.9%) 1 (1.3%); B 
henselae and B clarridgeiae 
1(0.9%) 1 (1.3%) ; ELISA:  
Bartonella species 22 (26.5%) 
20 (32.8%) 2 (9.1%) 
 
UNITED 
KINGDOM  
       
AD Bennett et 
al 
2011 Journal of 
Feline Medicine 
and Surgery 
(2011) 13, 
553e557 
78 78 cats were entered 
into the study. Of the 
cats, 61 were client-
owned and 17 were 
from rescue 
centres; 40 were 
clinically ill and 38 were 
considered 
healthy 
PCR on blood 
semples 
Scotland B henselae 5.8% 
USA         
B J. Luria et al 2004 Journal of 
Feline 
Medicine and 
Surgery (2004) 
6, 287e296 
553 feral casts IFA >1:64 Northern 
Florida 
B. henselae 33.6 (186/553) 
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J B Case et al 2006 Journal of 
Feline 
Medicine and 
Surgery (2006) 
8, 111e117 
170  domestic cats living 
in private homes, 
feral cat colonies, and 
animal shelters from 
California and 
Wisconsin 
IFA USA 14.7% for Bartonella 
henselae 
A M Ishak et 
al 
2007 Journal of 
Feline 
Medicine and 
Surgery (2007) 
9, 1e7 
89 cats 
with 
anemia; 
87 healthy 
cats 
the blood of cats with 
anemia and a control 
group of healthy cats 
PCR USA Bartonella 
species was amplified from 
five of 89 cats with anemia 
(5.6%) and seven of 87 
healthy cats (8.0%)" 
CANADA        
A Kamrani et al 2008 The Canadian 
Journal of 
Veterinary 
Research 
2008;72:411–
419 
646 
healthy pet 
cats; 45 
feral cats; 
50 fleas  
healthy pet cats in 
Ontario 
PCR Canada Healthy cats: Bartonella spp. by 
PCR and by culture combined 
was 4.3% (28/646) [3.7% 
(24/646) Bartonella 
henselae, 0.6% (4/646) 
Bartonella clarridgeiae]; feral 
cats: The prevalence of 
Bartonella henselae (58%); 
fleas: B. henselae 90% (45/50); 
B. clarridgeiae 12% (6/50) 
AFRICA        
R Lobetti and 
M R Lappin 
2012 Journal of 
Feline Medicine 
and Surgery 14 
(2012) 857–862 
102   PCR+ELISA South Africa PCR: cats [Bartonella henselae: 
five cats (4.9%); Bartonella 
clarridgeieae: three cats (2.9%). 
ELISA:  
cats, 24 (23.5%) 
wereseropositive for Bartonella 
IgG 
 
AUSTRALIA        
14 
 
VR Barrs et al 2010 Australian 
Veterinary 
Journal 
Volume 88, 
No 5, May 
2010 
111 cats  PCR+ELISA easthern 
Australia 
PCR: 11/42 (26.2%) were 
positive for Bartonella spp. 
DNA in their blood. 
ELISA:  
Bartonella spp. IgG was 
detected in 42 cats 
(37.8%), of which  
 
ASIA        
A S Mokhtar 
and S  Tay 
2011 Am. J. Trop. 
Med. Hyg., 
85(5), 2011, 
pp. 931–933 
209 fleas;  209 fleas 
(Ctenocephalides 
felis);  
PCR Malaysia B. henselae 11.5%;  
B. clarridgeiae 19.1% 
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1.4 EHRLICHIOSIS 
Ehrlichia are vector-borne, Gram-negative, obligate intracellular bacteria. In 
Europe, Ehrlichia canis is the aetiological agent of canine monocytic ehrlichiosis 
(CME). This pathogen infects mainly lymphocytes and monocytes wherein the 
typical, microscopically visible microcolonies (morulae) develop. The main host 
of E. canis is the dog (other canids can serve as reservoirs of infection); the 
vector is the tick Rhipicephalus sanguineus. All stages (larvae, nymphs, adults) of 
R. sanguineus preferentially feed on canids and may acquire E. canis from 
bacteraemic animals. The pathogen may overwinter in infected ticks. Trans-
stadial (from larva to nymph to adult), but probably no transovarial, transmission 
occurs (ESCCAP). Ehrlichia canis or a closely related species has been described 
in cats (ESCCAP). For many years, Ehrlichia-like inclusions have been detected 
in monocytes, lymphocytes and granulocytes of cats with febrile illness and 
thrombocytopenia in many countries (Buoro et al., 1989, Bouloy et al., 1994, 
Beaufils et al., 1999, Bjoersdorff et al., 1999), as has serological evidence of 
Ehrlichia infection (Peavy et al., 1997, Matthewman et al., 1996, Beaufilset al., 
1999). Molecular techniques conﬁrmed the presence of E. canis in cats with 
clinical signs compatible with monocytic ehrlichiosis in North America 
(Breitschwerdt et al., 2002).  
As in other species, ehrlichiosis in cats is presumed to be tick-transmitted, but 
definitive evidence for the route of transmission is lacking (Shaw et al., 2001). 
Risk factors associated with positive serology for E canis and/or E risticii have 
been studied (Stubbs et al., 2000) and  cats with outdoor exposure are more 
likely to have positive E canis and/or E risticii serology; while there is no 
association with breed or age. Clinical signs reported in cats with ehrlichiosis are 
extremely varied. For the monocytic ehrlichiosis, the signs are: intermittent fever, 
anorexia, weight loss, vomiting and diarrhoea. Clinical-pathological discoveries 
include anaemia, thrombocytopenia, leukopenia and hyperglobulinaemia. It is 
still unknown whether cats become persistently infected or develop immunity as 
a result of chronic infection, similar to what happens with dogs (Shaw et al., 
2001). No association with FIV or FeLV has been reported in literature (Shaw et 
al., 2001). Definite diagnosis of feline ehrlichiosis is made by demonstration of 
intra-leucocytic inclusions in, or PCR of, a peripheral blood sample. However, 
the presence of inclusions in infected cats is variable (Stubbs et al., 2000, 
Bjoersdorff et al., 1999). Serological (IFA) testing is available for both E risticii 
and E canis infections in cats (Stubbs et al., 2000) but considerable cross-
reaction occurs between ehrlichial species and a rising titre is required to confirm 
active infection. Although controlled therapeutic trials are lacking, administration 
of doxycycline or tetracycline is the treatment of choice for feline ehrlichiosis 
and clinical response is reported to be excellent (Peavy et al., 1997, Bjoersdorff et 
16 
 
al., 1999, Beaufils et al., 1999). Antibiotic therapy should be administered for a 
minimum period of 21–28 days. The primary measure for the prevention of 
Ehrlichia infections is an effective protection against tick infestation (ESCCAP). 
E. canis is not considered a zoonotic agent (ESCCAP).  
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Authors Year  Journal  Number 
of tested 
cats  
Characteristics of 
feline population  
Methods  Location  Prevalence Notes 
EUROPE         
ITALIA         
S. Vita et al 2005 Veterinary 
Research 
Communicati
ons, 29(Suppl. 
2) (2005) 319–
321 
203  IFI assays 
and all 
samples were 
initially tested 
at a dilution 
of 1:40 
central Italy 
(Abruzzo) 
1% E.canis a mother and 
a son, who 
had been 
mainly living 
indoors and 
who had 
antibody 
titers of 1: 
160 and 
1:2560, 
respectively 
SPAIN         
E AGUIRRE 
et al 
2004 Ann. N.Y. 
Acad. Sci. 
1026: 103–105 
(2004) 
122  cats IFAT+PCR central Spain IFAT: E. 
canis 10% 
PCR: 0% 
 
A. Ortuno 2005 J. Vet. Med. B 
52, 246–248 
(2005) 
235 cats IFA Northeastern 
Spain 
17.9%. Most 
positive sera 
(83.3%) 
showed low 
antibody 
titres (<1:80) 
Laia Solano-
Gallego et al 
2006 Veterinary 
Microbiology 
118 (2006) 
274–277 
168  IFAT+PCR northeastern 
Spain 
IFAT: 11.3% 
PCR:0% 
 
M D Tabar et 2008 Veterinary 100 cats PCR Barcelona area; 1%  
18 
 
al Parasitology 
151 (2008) 
332–336 
Spain  
T. Ayllo´n et al 2009 Journal 
Compilation 
15 (2009) 
(Suppl. 2), 4–5 
52  client-owned cats PCR central Spain 3.8%  
Tania Ayllo´n et 
al 
 
2012 
 
VECTOR-
BORNE AND 
ZOONOTIC 
DISEASES 
Volume 12, 
Number 2, 
2012 
 
680 
 
680 (539 (79.3% of 
total) client-owned cats 
; 141 (20.7% of total) 
stray cats were enrolled 
at five humane societies 
in the Madrid 
area) 
 
IFA (Cut-off 
titers were 
established at 
1:40)+ PCR 
 
Madrid, Spain. 
 
stray cats 
6.4% (n = 9); 
client-owned 
cats 10.8% (n 
= 58); All cats  
in 67/680 
9.9%, 
PCR: 0% 
 
IRLANDA         
F Juvet et al 2010 Journal of 
Feline 
Medicine and 
Surgery (2010) 
12, 476e482 
116 whole 
blood 
41 client-owned and 
75  stray cats 
PCR IRLANDA 0%  
UNITED 
KINGDOM  
        
AD Bennett et 
al 
 
2011 
 
Journal of 
Feline Medicine 
and Surgery 
(2011) 13, 
553e557 
 
78 
 
78 cats were entered 
into the study. Of the 
cats, 61 were client-
owned and 17 were 
from rescue 
centres; 40 were 
clinically ill and 38 were 
considered 
healthy 
 
PCR 
 
Scotland 
 
0% 
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USA          
J M Eberhardt 
et al 
2006 Journal of 
Feline 
Medicine and 
Surgery (2006) 
8, 164e168 
112 cats feral and relinquished 
cats in Phoenix and 
Nogales, Arizona 
PCR USA 0%  
M R Lappin et 
al 
2006 Journal of 
Feline 
Medicine and 
Surgery (2006) 
8, 85e90 
92 whole 
blood 
semples 
cats brought to 
Veterinarians in 
Alabama (BG and 
AR), Maryland 
(Brunt), and Texas 
(Burney) 
PCR USA 0%  
AFRICA         
R Lobetti and 
M R Lappin 
2012 Journal of 
Feline 
Medicine and 
Surgery 14 
(2012) 857–
862 
102  PCR South Africa 0%  
AUSTRALIA         
VR Barrs et al 2010 Australian 
Veterinary 
Journal 
Volume 88, 
No 5, May 
2010 
111 cats  PCR easthern 
Australia 
0%  
ASIA         
A S Mokhtar 
and S  Tay 
2011 Am. J. Trop. 
Med. Hyg., 
85(5), 2011, 
pp. 931–933 
209  fleas ( 
Ctenocephalides felis) 
PCR Malaysia R. felis 2.9%  
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1.5 RICKETTSIAL INFECTIONS  
These arthropod-transmitted, intracellular infections are rarely reported to cause 
clinical disease in cats. However, as domestic cats are susceptible to infection 
with a number of rickettsial species and are hosts for their arthropod vectors, 
they may play an increasingly important role in the epidemiology of these 
diseases in humans (Shaw et al., 2001). The spotted fever group of rickettsiosis 
are significant problems for man and dogs. In the Americas, Rocky Mountain 
spotted fever caused by Rickettsia rickettsia (transmitted by Dermacentor 
andersoni, D. variablis, R. sanguineus and Amblyomma cajennese) is the most 
important of this group, while in Europe, Asia and Africa, Mediterranean 
spotted fever caused by R. conorii (transmitted by R. sanguineus) is of greatest 
concern. The role of dog in these human infections is in transporting infected 
ticks into the domestic environment and the risk to owners of removing infected 
ticks from their animals (Days, 2011). Seropositivity indicates cats are also 
susceptible to infection with these tick-transmitted rickettsial species (Greene & 
Breitschwerdt 1998; Matthewman et al., 1997b). Clinical disease associated with 
infection has not been identified in cats. Whether cats play a role in the 
epidemiology of these diseases through interaction with the wild rodent reservoir 
of infection and ticks is unknown (Shaw et al., 2001).  
In these group of infections there are also two causes of flea-transmitted human 
typhus, Rickettsia typhi transmitted by rodent fleas with a world-wide 
distribution and the recently characterised and closely related R. felis in south-
western USA (Schriefer et al., 1994a, 1994b, Higgins et al., 1996b). The reservoir 
potential for domestic pets for R. typhi is not proven, but  R. felis is found in 
dogs, cats and cat fleas (Ct. felis) (McElroy KM et al., 2010; Kenny MJ et al., 
2003). R. felis may be transmitted transovarially and trans-stadially in successive 
generations of  Ct. felis and infection can be maintained in cats fleas for up 12 
generations without the fleas having fed on an infected hosts. Infection has also 
been transmitted among cats by infected fleas (C.E. Greene et al., 2013).  Thus 
the domestic pet may introduce infected fleas into the home environment, which 
then become the means for human infection. So Ct felis is now a recognised 
vector for typhus and will support infections with both rickettsial species 
(Noden et al., 1998). This vector has a catholic host range and is particularly well 
adapted to feed on opossums and cats. In endemic areas of the USA, peri-urban 
opossums are major reservoir hosts for R felis (Schriefer et al., 1994b) but the 
reservoir potential of cats has not been determined. Experimental infection of 
cats with R felis has been demonstrated (Wedincamp et al., 2000) as has 
seropositivity to R typhi (Sorvillo et al., 1993, Matthewman et al., 1997b). The 
pathogenic potential of either rickettsial species for cats is unknown. What is in 
no doubt, is that cats will transport Ct felis into domestic surroundings and as 
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transovarial and trans-stadial transmission of R felis has been shown (Azad et al., 
1992), a domestic focus of infection for humans could be established.  
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Authors Year  Journal  Number 
of tested 
cats  
Characteristics of 
feline population  
Methods  Location  Prevalence Notes 
EUROPE         
ITALIA         
G Capelli et al 2009 Parasites & 
Vectors 2009, 
2(Suppl 1):S8 
320 fleas 
(257 C. 
felis and 
63 C. 
canis) 
257 C. felis and 63 C. 
canis from 117 
animals 
PCR north-eastern 
Italy 
11.9% 38 (11.9%) 
C. felis fleas, 
13 from cats 
(17.6%) and 
25 from dogs 
(10.2%) 
werepositive 
for R. felis 
SPAIN         
E AGUIRRE 
et al 
2004 Ann. N.Y. 
Acad. Sci. 
1026: 103–105 
(2004) 
122  cats IFA central Spain N. risticii 
2.4% 
 
Laia Solano-
Gallego et al 
2006 Veterinary 
Microbiology 
118 (2006) 
274–277 
168 cats   IFA northeastern 
Spain 
R. conorii 
44% 
 
M D Tabar et 
al 
2008 Veterinary 
Parasitology 
151 (2008) 
332–336 
100 cats PCR Barcelona area; 
Spain 
R spp. 1%  
Tania Ayllo´n et 
al 
 
2012 
 
VECTOR-
BORNE AND 
ZOONOTIC 
DISEASES 
Volume 12, 
Number 2, 
680 
 
680 (539 (79.3% of 
total) client-owned cats 
; 141 (20.7% of total) 
stray cats were enrolled 
at five humane societies 
in the Madrid 
IFA (Cut-off 
titers were 
established at 
1:40)+ PCR 
 
Madrid, Spain. 
 
IFAT:stray 
cats 2.1% (n = 
3) for 
N. risticii; 
client-owned 
cats 0.7% (n = 
 
23 
 
2012 
 
area) 
 
4) for N. 
risticii; all cats 
7/680 1%. 
PCR: 0% 
 
PORTUGAL          
A. S. Alves et al 
 
2009 
 
Journal 
Compilation 
2009 European 
Society of 
Clinical 
Microbiology 
and Infectious 
Diseases, CMI, 
15 (Suppl. 2), 
1–3 
 
32 fleas 
from Fifty-
one cats 
(domestic, 
shelter and 
stray) 
 
Fifty-one cats 
(domestic, shelter and 
stray) from Lisbon and 
E´vora 
PCR 
 
PORTUGAL 
 
29 of which 
(90.6%) were 
C. felis, one 
(3.1%)was C. 
canis and two 
(6.3%) were 
unidentifiable. 
Only C. felis 
fleas were 
infected, six 
(40.0%) with 
B. clarridgeiae 
and six 
(40.0%) with 
R. felis 
 
 
UNITED 
KINGDOM  
        
AD Bennett et 
al 
 
2011 
 
Journal of 
Feline Medicine 
and Surgery 
(2011) 13, 
553e557 
 
78 
 
78 cats were entered 
into the study. Of the 
cats, 61 were client-
owned and 17 were 
from rescue 
centres; 40 were 
clinically ill and 38 were 
considered 
healthy 
 
PCR 
 
Scotland 
 
0% 
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USA          
J B Case et al 2006 Journal of 
Feline 
Medicine and 
Surgery (2006) 
8, 111e117 
170  domestic cats living 
in private homes, 
feral cat colonies, and 
animal shelters from 
California and 
Wisconsin 
IFA USA 17.2% of cats 
for Rickettsia 
rickettsii 
14.9% for R 
akari, 4.9% 
for R typhi, 
11.1% for R 
felis 
 
M R Lappin et 
al 
2006 Journal of 
Feline 
Medicine and 
Surgery (2006) 
8, 85e90 
92 whole 
blood 
semples;  
92 fleas 
from the 
same cats 
 
cats brought to 
Veterinarians in 
Alabama (BG and 
AR), Maryland 
(Brunt), and Texas 
(Burney) 
PCR USA 0%  
J M Eberhardt 
et al 
2006 Journal of 
Feline 
Medicine and 
Surgery (2006) 
8, 164e168 
112 cats feral and relinquished 
cats in Phoenix and 
Nogales, Arizona 
PCR USA Neorickettsia 
risticii 0% 
0% 
D B Bayliss et 
al 
2009 Journal of 
Feline 
Medicine and 
Surgery (2009) 
11, 266e270 
90 cats 
with and 
without 
fever 
cats with and without 
fever 
IFA USA R felis: cats 
with fever 
5.6%; cats 
without fever  
2.2%;  
R rickettsii: 
cats with fever 
6.6%: cats 
without fever 
2,2% 
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CANADA         
A Kamrani et 
al 
2008 The Canadian 
Journal of 
Veterinary 
Research 
2008;72:411–
419 
45 fera 
cats; 50 
fleas 
feral cats and fleas PCR Canada Cats: R. felis 
0%; fleas:  R. 
felis 18% 
(9/50) 
 
AUSTRALIA         
VR Barrs et al 2010 Australian 
Veterinary 
Journal 
Volume 88, 
No 5, May 
2010 
111 cats  PCR easthern 
Australia 
0%  
ASIA         
A S Mokhtar 
and S  Tay 
2011 Am. J. Trop. 
Med. Hyg., 
85(5), 2011, 
pp. 931–933 
209  fleas ( 
Ctenocephalides felis) 
PCR Malaysia R. felis 2.9%  
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1.6 COXIELLOSIS 
Coxiella burnetii is an extracellular, arthropod-transmitted, spore-forming 
bacterium which in cats produces subclinical infection but in humans causes Q 
fever, a disease associated with fever, arthralgia, myalgia, hepatitis and respiratory 
symptoms. A wide range of wild and domesticated animals including cats are 
considered In wildlife reservoir cycles, C burnetii is commonly transmitted by 
arthropod vectors, including ticks. In addition, the sporulated form of C burnetii 
is highly resistant to environmental extremes and can be spread between hosts 
by ingestion or aerosol dissemination of infected fluids such as milk, urine and 
vaginal/uterine secretions, or by ingestion of infected tissues such as placental 
material (Shaw et al. 2001; Nagaoka et al., 1998). Cross-reactivity between C 
burnetii and B henselae has been reported in human studies (LaScola et al., 1996) 
and although this has not been investigated in cats, it may inflate seroprevalence 
figures for Coxiella (Shaw et al., 2001. 
Infected cats are considered important reservoirs for human coxiellosis (Shaw et 
al., 2001). C burnetii appears to be frequently carried in the vagina of healthy cats 
in endemic areas (Nagoaka et al., 1998) and contact with infected parturient cats 
is a risk factor for human infection (Pinsky et al., 1991, Morita et al., 1994). 
Diagnosis of active infection with Coxiella is made by demonstration of a rising 
antibody titre, PCR or immunohistochemical techniques. Treatment of cats may 
be required in households where there is increased risk of human infection. 
Coxiella infections are variably susceptible to single agent therapy with 
macrolides (erythromycin, azithromycin), potentiated sulphonamides and 
fluoroquinolones  for 2–4 weeks duration. Combination therapy of doxycycline 
and fluoroquinolones with rifampicin may be more effective (Shaw et al., 2001, 
Levy et al., 1991). 
 
1.7 YERSINIOSIS 
Yersinia pestis is non-spore-forming bacterium which  causes Plague. Infection 
is maintained in reservoir rodent populations by flea transmission. Localised foci 
of disease occur in temperate, semi-arid areas throughout the world and with 
semi-urban development now extending into endemic areas of plague, there is 
increasing risk of domestic cats being infected by bites from rodent fleas 
acquired during hunting, or morecommonly by ingestion of infected small 
mammals. Ct felis is a relatively ineffective vector for plague transmission. 
Bacteraemic cats are a source for human infection either directly through aerosol 
spread, bites or scratches or indirectly by transporting infected fleas into the 
domestic environment (Shaw et al., 2001, Macy, 1998, Gage et al., 2000). Both 
domesticated and wild cats are more susceptible to clinical yersiniosis than dogs. 
In experimentally infected cats, most develop mild to moderately severe clinical 
disease with subsequent recovery, although some develop an acute fulminating 
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and fatal syndrome (Gasper et al., 1993). In naturally infected cats are described 
two main clinical syndromes:Bubonic plague associated with fever, dehydration, 
weight loss and lymphadenopathy with abscessation and draining tracts affecting 
the cervical, retropharyngeal and submandibular lymph nodes, which may be 
followed by recovery or by haematogenous spread with progression to the often 
fatal, septicaemic syndrome. In cats, pneumonic involvement during this stage is 
common and dissemination by aerosol may occur to in-contact humans. 
Less commonly reported gastrointestinal syndrome with vomiting, diarrhoea, 
tonsillar and lingual lymph node enlargement and necrotic stomatitis (Eidson et 
al., 1991, Carlson, 1996). 
Fluorescent antibody testing and rising serological titres provide a presumptive 
diagnosis. Confirmation of diagnosis is made by demonstration of bacteria in 
affected tonsillar tissue or lymph node aspirates with appropriate Gram and 
Giemsa staining characteristics, followed by culture. Stringent biosafety 
procedures should be carried out in collection and transport of specimens and 
culture requires a containment laboratory. The decision to treat cats with plague 
should always take into consideration the zoonotic risk. In particular, the 
potential for aerosol spread from pulmonary lesions in infected cats should be 
evaluated by thoracic radiology. Appropriate protective clothing and gloves 
should be worn and all contaminated material or surfaces should be disinfected. 
Yersinia pestis is sensitive to routine disinfectants and a variety of antibiotics 
including aminoglycosides, doxycycline, chloramphenicol and fluoroquinolones . 
Fluorescent antibody testing and rising serological titres provide a presumptive 
diagnosis. Confirmation of diagnosis is made by demonstration of bacteria in 
affected tonsillar tissue or lymph node aspirates with appropriate Gram and 
Giemsa staining characteristics, followed by culture. Stringent biosafety 
procedures should be carried out in collection and transport of specimens and 
culture requires a containment laboratory. The decision to treat cats with plague 
should always take into consideration the zoonotic risk. In particular, the 
potential for aerosol spread from pulmonary lesions in infected cats should be 
evaluated by thoracic radiology. Appropriate protective clothing and gloves 
should be worn and all contaminated material or surfaces should be disinfected. 
Yersinia pestis is sensitive to routine disinfectants and a variety of antibiotics 
including aminoglycosides, doxycycline, chloramphenicol and fluoroquinolones 
(Shaw et al., 2001, Bonacorsi et al., 1994). Therapy should be continued for a 
minimum of 21 days. Doxycycline is most commonly used in the bubonic 
syndrome and can be used for prophylaxis in exposed, subclinical cats (Shaw et 
al., 2001, Macy 1998). 
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1.8 TULARAEMIA 
The aetiological agent of tularaemia in mammals and birds is the tick-transmitted 
bacterium, Francisella tularensis. These organisms are distributed throughout the 
temperate and sub-Arctic areas of the northern hemisphere and there is 
geographic variation in strain, the species of tick vector and reservoir hosts 
involved. Two biovars are recognised and cats are susceptible to both (Baldwin 
et al., 1991). F tularensis tularensis is distributed throughout North America and 
is associated with a tick-rabbit cycle. F tularensis palearctica has a broad 
distribution throughout the northern hemisphere and has a more complex 
epidemiology involving a hare/rabbit reservoir-tick/mosquito cycle. Tick vectors 
include species of Dermacentor, Ambylomma, Ixodes and Haemaphysalis. Cats 
may also be infected by ingesting infected rodent or lagomorph prey. Infected 
domestic cats may transmit tularaemia to humans by bites and scratches 
(Capellan et al., 1993, Rodon et al., 1998, Arav-Boger 2000). Cats appear more 
susceptible to naturally occurring clinical tularaemia than dogs and younger cats 
appear more predisposed. Clinical signs include fever, marked lethargy, anorexia, 
regional or generalised lymphadenopathy with abscessation, splenomegaly 
and/or hepatomegaly with abscessation, oral ulceration, leucopenia, icterus and 
in some cases death (Baldwin et al., 1991, Gliatto et al., 1994, Woods et al., 
1998). Presumptive diagnosis may be made serologically but confirmation 
requires culture of infected tissue or body fluids using rigorous biosafety 
procedures to prevent human infection. Therapeutic regimes for feline 
tularaemia have not been thoroughly investigated and are adapted from human 
cases. Aminoglycoside, tetracycline, chloramphenicol and fluoroquinolone 
antibiotics have been advocated for 2–4 weeks duration (Enderlin et al., 1994). 
 
1.9 BORRELIOSIS 
There are currently 11 known species/genotypes of the Borrelia burgdorferi 
complex (=sensu lato) which are spirochaetes that infect many mammals and 
birds and are transmitted by ticks (Ixodes ricinus, I. hexagonus, and I. 
persulcatus) (ESCCAP). Human infections are of major public health 
importance and although infections have been demonstrated in dogs, they are 
not of major clinical importance. Humans as well as dogs acquire Borrelia 
infection when exposed to infected ticks but there is no interdependency 
between dogs and humans in terms of transmission. Positive serology in cats has 
also been reported, but disease in cats, if it occurs at all, is poorly understood 
and there is therefore little data concerning the prevalence of infection, clinical 
appearance and treatment options for cats (ESCCAP).  Currently, ticks of the 
family Ixodidae and mostly of the genus Ixodes are recognized vectors of B. 
burgdorferi. Larval, nymph and adult female tick vectors can acquire Borrelia 
when feeding on an infected “reservoir host”, which is an animal harbouring the 
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pathogen as a long-term infection. It is also the case that ticks can become 
infected with the spirochaetes when feeding next to infected ticks (co-feeding 
transmission).  Several animal species have been identified as reservoirs of 
Borrelia in Europe, including many mammals and birds. Borrelia in ticks 
disseminate to the salivary glands and are transmitted trans-stadially but there is 
no transovarial transmission. The tick must be attached for at least 16-24 hours 
before pathogen transmission to a new host occurs.  Borrelia remains in the skin 
of a host before travelling to other tissues. In some cases, it can take up to 4 
weeks before a systemic infection develops (ESCCAP). Much of the published 
borreliosis research in dogs and cats relates to the Genogroup I species, B. 
burgdorferi sensu stricto, which is the main cause of borreliosis in humans and 
dogs in the USA. However, B garinii and B afzelii are the major pathogenic 
species for humans in Europe and in Japan, B japonica causes human disease 
(Shaw et al., 2001, Dressler et al., 1994, Wilske et al., 1996, Hubalek, et al.,1997).  
The results of experimental infection of cats with US strains of B burgdorferi are 
contradictory with respect to inducing clinical signs. Burgess (1992) reported no 
apparent disease following infection while others (Gibson et al.,  1993, Omran et 
al., 1997) reported some cats with non-specific signs including fever, lethargy, 
stiffness and arthritis. Clinical and pathological signs referable to hepatic, 
gastrointestinal, neurological and cardiac disease are also reported (Omran et al., 
1997). There is some evidence that persistent infection without disease may 
occur (Shaw et al., 2001).   Clinical manifestations in naturally-infected cats are 
uncommon (ESCCAP). Clinical borreliosis has not been fully characterized but 
techniques used to indicate infection in cats include PCR and serology. Cyclical 
increases in both B burgdorferi-specific IgM and IgG levels with associated 
neutropenia have been reported in experimentally infected cats (Omran et al 
1997). Detection of Borrelia by culture, cytology or PCR may be difficult, 
timeconsuming and expensive. The organism is rarely found in blood, urine, 
joint fluid or CSF, but can be detected in skin and synoviae. Therapeutic 
protocols have not been specifically described for cats. However, doxycycline, 
amoxicillin, azithromycin, penicillin, ceftriaxone and cefotaxime are used in 
human and canine cases  and duration of therapy should extend to 30 days 
(Shaw et al., 2001). 
 
1.10 ANAPLASMOSIS 
Anaplasma spp. are vector-transmitted, Gram-negative, obligate intracellular 
bacteria. In Europe, A. phagocytophilum (formerly Ehrlichia phagocytophila) 
and A. platys (formerly E. platys) have been reported from domestic dogs. They 
infect predominantly neutrophil and rarely eosinophil granulocytes (A. 
phagocytophilum) or platelets (A. platys), respectively, and develop into typical 
microcolonies (morulae) that are observable by light microscopy (ESCCAP). 
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Anaplasma phagocytophilum is the agent of Canine granulocytic anaplasmosis 
(CGA); it can infected dogs, cats, humans, horses, sheep, roe deer, red deer, 
small rodents, goats, cattle, llamas which are recognized as reservoir and while 
Ixodes ricinus is recognized as its vector tick in nonfeline hosts (ESCCAP) 
(Greene). Trans-stadial but not transovarial transmission of A. phagocytophilum 
occurs in the Ixodes vector. Usually, tick feeding for 24-48 hours is required for 
the transmission of this agent to susceptible dogs. The incubation period in the 
mammalian host is 1 to 2 weeks. After endocytosis, A. phagocytophilum 
develops by binary fission into morulae in the phagosomes predominantly of 
neutrophils and rarely eosinophils. Cells infected with A. phagocytophilum are 
found in the circulating blood as well as in the tissues of the mononuclear 
phagocytic system, such as the spleen, liver and bone marrow (ESCCAP). The 
geographical distribution of infections with A. phagocytophilum generally 
correspond to the distribution of their respective (or supposed) tick vectors. 
With increasing travel of dogs with their owners, infections must also be 
expected to occur in previously non-endemic areas (ESCCAP). Reports of 
Anaplasma spp. infections in cats are rare. Of the naturally infected cats with A. 
phagocytophilum DNA in the blood, all lived in an I. scapularis, I. pacificus or I. 
ricinus endemic region, all were presumed to be allowed to roam outdoors, and 
four were known to be infested by Ixodes spp. At the time of inizial 
examination. Therefore, this genus of ticks can also likely serve as the vector 
transmitting A. phagocytophilum to cats. C. felis taken from cats in United 
States, Portugal and Australia had negative test results for Anaplasma spp. DNA. 
Rodents are commonly infected with A. phagocytophilum; however it is 
unknown whether ingestion of or direct contact with rodents plays a role in A. 
phagocytophilum infection in cats (M.R.Lappin and E.B. Breitschewerdt, Greene 
4th ed.). Cats with A. phagocytophilum infections suffer from lethargy, anorexia, 
fever, lymphadenopathy, anaemia and thrombocytopaenia (ESSCAP; Bjoersdorff 
et al 1999, Shaw 2001, Lappin et al 2001). The diagnosis of Anaplasma spp. 
Infections is generally based on serology and/or PCR. Antibodies may be 
detected by indirect immunofluorescent assay (IFA) using A. phagocytophilum 
antigens. Seroconversion may occur 1-4 weeks after exposure and, thus, cats 
with acute infections can be serologically negative. Additionally, in endemic 
areas, positive IFA results may result from a previous infection and may not 
necessarily be indicative of an acute infection. Generally, two serological tests at 
an interval of 2-3 weeks need to be carried out to monitor if seroconversion has 
occurred. A positive result of a single serological test combined with clinical 
signs is not sufficient evidence for a diagnosis of anaplasmosis. Specific assays 
for the detection of A. phagocytophilum and A. platys are performed by 
specialized laboratories. A PCR-positive result generally confirms an infection. A 
PCR-negative result does not exclude the possibility of an infection. A definitive 
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diagnosis is made when morulae can be observed in neutrophil (and more rarely 
eosinophil) granulocytes (A. phagocytophilum)  on microscopical examination of 
blood smears. To increase the diagnostic sensitivity, buffy coat smears should be 
examined. Positive results should be confirmed by PCR analysis. The treatment 
of anaplasmosis consists of the administration of antirickettsial agents and 
symptomatic treatment. Tetracyclines are the most commonly used compounds, 
with doxycycline at a dosage of 10 mg/kg/day over 3-4 weeks being the most 
commonly used treatment scheme. With correct treatment, the prognosis of A. 
phagocytophilum infections is fairly good. The primary measure for the 
prevention of Anaplasma infections is an effective protection against tick 
infestations (ESCCAP). Thus,  exposure of cats to potential arthropod vectors 
should be avoided or tick control maintained with acaricidal products that are 
approved for use on cats (Lappin et al., 2013). A. phagocytophilum can likely be 
transmitted by blood; therefore, cats used as blood donors should be screened 
for infection by using serum antibody tests or PCR assays, and positive cats 
should be excluded as donors. Although A. phagocytophilum is known to infect 
both people and cats, no association has ever been exhibited between human 
infection and cat contact. If cats are housed indoor and arthropod control is 
maintained, the risk to people should be minimal (Lappin eta al., 2013). 
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Authors Year  Journal  Number 
of tested 
cats  
Characteristics of 
feline population  
Methods  Location  Prevalence 
ITALY        
W. Tarello 
 
2005 
 
Veterinary 
Record 
(2005)156, 772-
774 
 
250 
 
 
cats from Italy with 
Ehrlichia-like inclusion 
bodies in their neutrophils 
 
cytological 
demostration 
of ehrlichial 
morulae in 
neutrophils; 
characteristic 
signs of 
disease; 
absence of 
concurret 
conditions; 
responce to 
treatment to 
doxycyclina 
 
central Italy 
 
15/250 (6%) 
 
EUROPE        
SPAIN        
E AGUIRRE et 
al 
2004 Ann. N.Y. 
Acad. Sci. 1026: 
103–105 (2004) 
122  cats IFA + PCR central Spain  4.9% IFAT; 
0% PCR 
Laia Solano-
Gallego et al 
 
2006 
 
Veterinary 
Microbiology 
118 (2006) 274–
277 
 
168 
 
cats 
 
IFAT+PCR northeastern 
Spain  
 
11,30% 
IFAT; 
0% PCR 
M D Tabar 2008 Veterinary 
Parasitology 
151 (2008) 332–
336 
100 cast PCR Barcelona area; 
Spain 
1% 
T. Ayllo´n et al 2009 Journal 52  client-owned cats PCR central Spain 7.7% 
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Compilation 15 
(2009) (Suppl. 
2), 4–5 
Tania Ayllo´n et 
al 
2012 VECTOR-
BORNE AND 
ZOONOTIC 
DISEASES 
Volume 12, 
Number 2, 
2012 
680 client-owned and stray 
cats from  
IFAT+PCR Madrid, Spain. IFAT stray 
cats: 9.1% (n 
= 8); client-
owned cats 
5.7% (n = 49); 
all cats 57/680 
8.4%. 
PCR: 0%  
PORTUGAL         
A. S. Alves et al 2009 Journal 
Compilation 
2009 European 
Society of 
Clinical 
Microbiology 
and Infectious 
Diseases, CMI, 
15 (Suppl. 2), 
1–3 
18 fleas 
from Fifty-
one cats 
(domestic, 
shelter and 
stray) 
Fifty-one cats 
(domestic, shelter and 
stray) from Lisbon and 
E´vora 
PCR PORTUGAL 0% 
IRLANDA        
F Juvet et al 2010 Journal of 
Feline Medicine 
and Surgery 
(2010) 12, 
476e482 
116 whole 
blood 
41 client-owned and 75  
stray cats 
PCR IRLANDA 0% 
UNITED 
KINGDOM  
       
S. E. Shaw et al 2005 Veterinary 
Record 
(2005)157, 645-
648 
60 cats  ill owned cats PCR UNITED 
KINGDOM 
1.6% 
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AD Bennett et 
al 
2011 Journal of 
Feline Medicine 
and Surgery 
(2011) 13, 
553e557 
78 78 cats were entered 
into the study. Of the 
cats, 61 were client-
owned and 17 were 
from rescue 
centres; 40 were 
clinically ill and 38 were 
considered 
healthy 
PCR Scotland 0% 
AFRICA        
R Lobetti and 
M R Lappin 
2012 Journal of 
Feline Medicine 
and Surgery 14 
(2012) 857–862 
102   PCR South Africa 0% 
USA         
J M Eberhardt 
et al 
2006 Journal of 
Feline Medicine 
and Surgery 
(2006) 8, 
164e168 
112 cats feral and relinquished 
cats in Phoenix and 
Nogales, Arizona 
PCR USA 0% 
M R Lappin et 
al 
2006 Journal of 
Feline Medicine 
and Surgery 
(2006) 8, 85e90 
92 whole 
blood 
semples 
cats brought to 
Veterinarians in 
Alabama (BG and AR), 
Maryland (Brunt), and 
Texas (Burney) 
PCR USA 0% 
Sarah A. Billeter 
et al 
2007 Veterinary 
Parasitology 
147 (2007) 194–
198 
460 domestic felines IFA at a 1:50; 
PCR 
United States IFAT 4.3%; 
PCR 0% 
A M Ishak et al 2007 Journal of 
Feline Medicine 
and Surgery 
(2007) 9, 1e7 
89 cats 
with 
anemia; 87 
healthy 
cats 
the blood of cats with 
anemia and a control 
group of healthy cats 
PCR USA 0% 
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AUSTRALIA        
VR Barrs et al 2010 Australian 
Veterinary 
Journal Volume 
88, No 5, May 
2010 
111 cats   PCR easthern 
Australia 
0% 
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1.11 HAEMOTROPIC MICOPLASMAS INFECTIONS  
The haemotropic mycoplasmas (‘haemoplasmas’) are mycoplasmal bacteria that 
infect erythrocytes, attaching to the red blood cell surface (S. Tasker). These 
species, including Haemobartonella felis, renamed Mycoplasma haemofelis and 
two new feline species: ‘Candidatus Mycoplasma haemominutum’ and 
‘CandidatusMycoplasma turicensis’. One recent study from the USA suggested 
that cats could be further infected with an organism similar to one of the canine 
haemoplasmas called ‘Candidatus Mycoplasma haematoparvum’ (Sykes et al., 
2007). The feline haemoplasma species that are currently recognised vary in 
pathogenicity, with some isolates consistently inducing haemolytic anaemia 
whereas others result in few noticeable clinical signs. However, it is not only the 
infecting species or isolate that influences clinical signs — duration of infection 
and host factors, such as the presence of concurrent disease or retrovirus status, 
can also play a part. Age, too, may be important in that it has been suggested that 
younger cats are more susceptible to clinical haemoplasmosis (Sykes et al.,  2008;  
Tasker S et al., 2009). Other factors such as infecting organism dose or route of 
infection may also impact on outcome. Studies evaluating risk factors for 
haemoplasma infection have generally found that older male cats, with outdoor 
access, are more likely to be infected. The increased prevalence in male cats, 
together with reports that cat bite abscesses and outdoor roaming are risk 
factors, have led to the suggestion that horizontal transmission may occur via 
fighting. In line with this both ‘Candidatus M haemominutum’ and ‘Candidatus 
M turicensis’ DNA has been found in the saliva of infected cats (Willi et al., 
2006;.Dean et al., 2008). However, recent studies failed to show the successful 
transmission of ‘Candidatus M turicensis’ infection between cats by the oral or 
subcutaneous inoculation of ‘Candidatus M turicensis’-infected saliva, even 
though the same dose of ‘CandidatusM turicensis’ in blood led to successful 
transmission when inoculated subcutaneously (Museux et al., 2009). More work 
in this field is required but it seems probable that haemoplasma transmission via 
social contact is unlikely but that aggressive interaction (eg, cat bites) may result 
in transmission if the recipient cat is exposed to infectious blood rather than just 
saliva. The cat flea Ctenocephalides felis has been incriminated in the 
transmission of haemoplasmosis between cats although only transient 
transmission of M haemofelis to a cat via the haematophagous activity of Ct felis 
was demonstrated (Woods 2005). Studies have found evidence of feline 
haemoplasma infection in fleas collected from cats (Kamrani et al., 2008; ,Shaw 
et al., 2004; Lappin et al., 2006; Hornok et al., 20109and in some ticks (Willi et 
al., 2007; Tauroura et al., 2005).. Additionally, in one US study (Hackett et al., 
2006), community-sourced cats that were housed indoors without a history of 
ticks or fleas were less likely to have haemoplasma infections than those that had 
access outdoors or had a history of ticks or fleas. However , direct evidence for 
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the role of vectors in natural/field haemoplasma transmission between cats is 
lacking. It has been certainly seen haemoplasma transmission between cats in the 
absence of vectors so, even if fleas or ticks have the ability to act as vectors for 
haemoplasmosis in cats, other means of haemoplasma transmission must exist 
(Tasker et al.,2010). 
Transmission via contaminated blood transfusions has been reported (Willi et al., 
2006),4 and the use of freshly collected blood from a haemoplasma-infected 
blood donor for transfusion would very likely result in transmission of infection 
to the recipient cat. The risk of haemoplasma transmission when using stored 
blood for transfusions depends on the viability of haemoplasmas in stored 
blood. Other possible modes of haemoplasma transmission include vertical 
transmission from queen to kittens during pregnancy, at birth or via lactation. 
Although not reported, transmission may also be possible via the use of multi-
use vials between cats, or the inappropriate use of the same equipment (eg, 
surgical instruments) on different cats without adequate cleaning/sterilisation, 
particularly if blood contamination was significant and only a short time elapsed 
between consecutive procedures (Tasker et al., 2010). Most of the haemolysis 
associated with haemoplasma infection is believed to be extravascular in nature, 
occurring in the spleen and liver especially, but also in the lungs and bone 
marrow. Intravascular haemolysis has also been reported, as has increased 
osmotic fragility of haemoplasma-infected red blood cells (Willi et al., 2005) 
Positive Coombs' tests and autoagglutination, indicating the presence of 
erythrocyte-bound antibodies, have been demonstrated in anaemic M 
haemofelis-infected cats (Tasker et al., 2009) . Such erythrocyte-bound 
antibodies could be responsible for immune-mediated destruction of red blood 
cells. in most cats the erythrocyte-bound antibodies appeared only after anaemia 
had started to develop. The absence of erythrocyte-bound antibodies at the 
onset of development of anaemia could reflect a problem with the sensitivity of 
detection of erythrocyte-bound antibodies; however, an alternative explanation is 
that erythrocyte-bound antibodies appear as a result of haemoplasma-induced 
haemolysis, rather than initiating the haemolysis. Indeed it has been documented 
disappearance of these antibodies with antibiotic and supportive treatment alone, 
without the need for specific glucocorticoid treatment, questioning the key role 
of such antibodies in haemoplasma-induced anaemia.  the clinical signs of 
haemoplasma infection depend on factors such as the haemoplasma species 
involved, stage of infection and whether concurrent diseases or infections are 
present. Common signs exhibited by acutely ill cats include pallor, lethargy, 
anorexia, weight loss, depression and dehydration. Intermittent pyrexia is often 
seen, particularly in the acute stage disease, as is splenomegaly, which may reflect 
extramedullary haematopoiesis. Jaundice is uncommon unless severe acute 
haemolysis occurs. Cats that recover from haemoplasma infection may remain 
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chronically infected (Tasker et al., 2010). Long-term carrier status appears to be 
especially common following ‘Candidatus M haemominutum’ infection, although 
suspected clearance of this infection has been reported with and without 
antibiotic treatment (Willi et al., 2006). M. haemofelis-infected cats may 
spontaneously clear infection from peripheral blood after infection without 
antibiotic treatment, and such clearance has also been reported with ‘Candidatus 
M. turicensis’ infection. In any haemoplasma-infected carrier cat the potential for 
reactivation of infection exists, which can result in clinical disease (Foley et al., 
1998), although this seems to be quite rare once haemoplasma infection has 
become established beyond acute infection (Tasker et al., 2010). When anaemia 
is induced by haemoplasma infection, it is typically regenerative (or pre-
regenerative if sampling occurs very soon after the onset of anaemia), 
macrocytic, and normo- or hypochromic. However, significant reticulocytosis is 
not always present, even when pre-regenerative cases are excluded, possibly due 
to concurrent retroviral infections or other disease processes. Release of 
sequestered erythrocytes from the spleen may also result in a marked rise in red 
blood cell count without an accompanying reticulocytosis (Tasker et al., 2010). 
Serum biochemistry may reveal hyperproteinaemia due to dehydration or an 
acute phase response, and increased liver enzyme levels may arise from hepatic 
hypoxic damage. Hyperbilirubinaemia can result from the haemolysis (Tasker et 
al., 2009). Diagnosis of haemoplasma infection used to rely on cytological 
examination of a Romanowsky-stained blood smear, with organisms appearing 
on the surface of erythrocytes as rounded bodies singly, in pairs, or occasionally 
in chains. Diff-Quik or filtered Giemsa stains can be used. However, cytological 
diagnosis has poor sensitivity and specificity.  many cases diagnosed as being 
haemoplasma-infected on the basis of blood smear interpretation in practice 
have been false positives, with stain precipitate, Howell-Jolly bodies and artefacts 
due to slow blood smear drying being the most common reasons for error. 
Additionally cytology cannot differentiate between haemoplasma species (Tasker 
et al., 2010). Polymerase chain reaction is known to be more sensitive than 
cytology for haemoplasma detection. (S. Tasker et al., 2010)Quantitative PCR 
assays exist that amplify and differentiate all three feline haemoplasma species. 
Only a small amount of blood is required for PCR. Most diagnostic laboratories 
request 1 ml of anti-coagulated blood, although in reality PCR is usually 
performed using DNA extracted from smaller volumes of blood (0.1 or 0.2 ml). 
EDTA-anticoagulated blood is usually required since heparin inhibits PCR. 
DNA is quite stable within blood samples so rapid or cold shipping of samples is 
not required. Blood sampling for PCR should preferably be undertaken before a 
cat undergoes any antibiotic treatment (Tasker et al., 2010). Following recovery 
from acute clinical disease, cats can remain chronically infected. In some cases 
this chronic carrier status is lifelong, whereas in others anti biotic therapy or 
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spontaneous elimination of the organism results in apparent clearance of 
infection. Cats usually remain PCR positive during chronic carrier status. Up to 
10% of healthy cats at any time are infected with feline haemoplasmas (Kamrani 
et al., 2008; Tasker et al., 2003), emphasising that a positive PCR result does not 
always correlate with the presence of clinical haemoplasmal disease. This must 
be considered when interpreting haemoplasma PCR results. If haemoplasma 
infection is diagnosed in a cat showing clinical signs then treatment should be 
instigated, ideally to clear infection but certainly to induce a clinical response. 
Treatment is also indicated in cases with concurrent infections or diseases that 
could exacerbate the potential for disease due to haemoplasma infection (eg, in 
an immunosuppressed FIV-infected cat). In cases in which treatment is 
instigated, monitoring can be performed so that treatment efficacy can be 
assessed. Tetracycline and fluoroquinolone antibiotics are effective at reducing 
haemoplasma organism numbers in the blood, although consistent predictable 
elimination of haemoplasma infection has not been shown in any study.(Tasker 
et al., 2010)  However, antibiotics usually do improve clinical signs and 
haematological abnormalities associated with haemoplasma infection, even if 
elimination of haemoplasma infection does not always result. Cats clinically ill 
with haemoplasmosis are often profoundly dehydrated, so correction of this with 
intravenous fluid therapy is important. The degree of anaemia in 
haemoplasmosis cases may be masked by the dehydration causing 
haemoconcentration, so haematological parameters must be monitored after 
correction of dehydration. Encouraging food intake (eg, offering tempting 
warmed food, hand feeding) is important in inappetent cats. Although cats are 
often able to tolerate anaemia quite well, if the anaemia is severe (PCV <12%) 
and/or has developed acutely and is accompanied by significant associated 
clinical signs, a blood transfusion. Tetracyclines, such as oxytetracycline at a 
dosage of 22 mg/kg q8h PO (Tasker et al., 2002) , are usually effective in the 
treatment of haemoplasmosis. Doxycycline (10 mg/kg q24h PO) is usually the 
preferred tetracycline for the treatment of feline hemoplasmosis, with prolonged 
treatment courses (up to 8 weeks) recommended to increase the chance of 
eliminating infection (Tasker et al., 2004). Evidence exists for doxycycline 
efficacy against all three feline haemoplasma species, although controlled studies 
have only been performed for M haemofelis (Dowers et al., 2002; Tasker et al., 
2004;  Dowers et al., 2009). Fluoroquinolones are also often an effective 
treatment for haemoplasmosis. Enrofloxacin (5 mg/kg q24h PO) has been 
successfully used to treat M haemofelis infection in controlled studies. 
Marbofloxacin has also been effective at reducing M haemofelis and ‘Candidatus 
M haemominutum’ organism numbers in the blood of treated cats in controlled 
studies, using the recommended UK dosage of 2 mg/kg q24h PO, although the 
fall in ‘Candidatus M haemominutum’ organism numbers was less pronounced 
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than that of M haemofelis Tasker et al., 2006).The efficacy of 14 days of prado-
floxacin treatment of experimental M haemofelis infection has recently been 
reported (Dowers et al., 2009), where it was found to be effective (at the 
standard 5 mg/kg q24h PO dose, as well as a higher dose of 10 mg/kg q24h 
PO) at improving clinical signs and haematological values, and lowering M 
haemofelis copy numbers in the blood. It has been reported the anaemia induced 
by haemoplasma infection is in part immune-mediated and so corticosteroids 
have been recommended as adjunct therapy (VanSteenhouse et al., 
1993).However, the value of corticosteroids in the treatment of haemoplasmosis 
has not been proven and, as mentioned earlier, anaemic Coombs'-positive cats 
infected with M haemofelis respond to antibiotic treatment alone (Tasker et al., 
2009), which calls into question the need for immunosuppressive treatment. 
Indeed in some cases concurrent corticosteroid therapy has been associated with 
a delay in obtaining apparent haemoplasma clearance from the blood. It has 
been shown that a ‘Candidatus M turicensis’ infected cat that received 
methylprednisolone acetate prior to infection developed a more severe anaemia 
than an immunocompetent cat (Willi et al., 2005), so corticosteroids have the 
potential to exacerbate disease too. Corticosteroid treatment is recommended 
only considering corticosteroid treatment in cases that are deteriorating despite 
administration of an appropriate antibiotic and in which immunemediated 
haemolytic anaemia (IMHA) is thought to be a major component of the disease, 
or in cases in which haemoplasma infection is not strongly believed to be the 
underlying cause of disease in cases that are deteriorating despite administration 
of an appropriate antibiotic and in which immunemediated haemolytic anaemia 
(IMHA) is thought to be a major component of the disease, or in cases in which 
haemoplasma infection is not strongly believed to be the underlying cause of 
disease. 
Recently, PCR has been used to show evidence of haemoplasma infection in 
humans. PCR has documented the presence of an organism very similar to M 
suis in people in China, although clinical haemoplasmosis was not common. 
(Yuan et al., 2007; Yuan et al., 2009).  In another study, a M haemofelis-like 
organism was detected in an immunosuppressed HIV-positive patient who had 
concurrent bartonellosis and a history of cat scratches (Santos et al., 200). 
However, the contribution of the M haemofelis-like infection to the man's 
clinical signs was not discussed. These reports certainly suggest the existence of 
zoonotic haemoplasma infections, which will need to be further investigated to 
clearly define the epidemiology of human haemoplasmosis. 
 
1.12 CYTAUXZOONOSIS 
Cytauxzoonosis is a tick-transmitted protozoal disease caused by Cytauxzoon 
felis affecting wild and domestic felids (Meinkoth and Kocan, 2005). It was 
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described in several south central, south eastern (Meinkoth and Kocan, 2005), 
and mid-Atlantic states of the USA (Birkenheuer et al., 2006). The presumed 
main reservoir host of this infection appears to be the wild felid bobcat (Lynx 
rufus) (Kocan et al., 1985). Ticks are considered the vector and transmission of 
C. felis by Dermacentor variabilis (Blouin et al., 1984) and Amblyomma 
americanum (Reichard et al., 2010) has been demonstrated experimentally. C 
felis has developmental stages in both macrophages and erythrocytes of infected 
cats. In experimentally infected cats, proliferation of organisms in mononuclear 
phagocytic cells particularly in the lungs, results in marked vascular damage and 
occlusion, release of inflammatory mediators and DIC. The intra-erythrocytic 
stage induces both intravascular and extravascular haemolysis (Hoover et al., 
1994). This produces a rapidly progressive syndrome in most cats characterized 
by acute fever, haemolytic anaemia, lymphadenomegaly, anorexia, dyspnoea, and 
in severe cases, poor peripheral perfusion followed by hypothermia, coma and 
death (Shaw et al., 2001). The most common clinicopathological ﬁndings are 
anemia, depression, anorexia, vomiting, icterus, splenomegaly, hepatomegaly and 
high fever (Birkenheuer et al., 2006). Hypothermia typically develops just prior 
to the death (Greene et al., 2006). Historically, it was thought that the disease 
was always fatal in domestic cats. However, survival after infection (Walker and 
Cowell, 1995) and persistent blood parasitemia without clinical illness (Brown et 
al., 2008, 2010) have been documented in a few cases. In contrast, wild felids 
rarely manifest clinical illness and generally develop a subclinical 
erythroparasitemia (Meinkoth and Kocan, 2005). Nevertheless, occasional cases 
of fatal cytauxzoonosis, with clinical signs and large schizont-ﬁlled 
macrophageswithin blood vessels, have been reported also in wild felids (Carli et 
al., 2012; Garner et al., 1996; Nietfeld and Pollock, 2002; Peixoto et al., 2007). 
Interestingly, in the last years, other species of Cytauxzoon infecting wild and 
domestic felids have sporadically been described. A new species of Cytauxzoon 
named Cytauxzoon manul was molecularly characterized from a Pallas’ cat 
imported into Oklahoma from Mongolia (Ketz-Riley et al., 2003; Reichard et al., 
2005). Moreover, molecular recognition of a Cytauxzoon-like parasite was 
documented in a domestic cat (Criado-Fornelio et al., 2004) and Iberian Lynx 
from Spain (Luaces et al., 2005; Millán et al., 2007, 2009). Recently, Hepatozoon 
canis and Cytauxzoon sp. co-infection has been described in a cat from France 
(Criado-Fornelio et al., 2009) and a clinical cytauxzoonosis has been described in 
three cats from Trieste (Italy) ( Carli et all 2012). Unfortunately, there is paucity 
of information about epidemiological and clinic-pathological aspects of infection 
by species of Cytauxzoon other than C. felis. Diagnosis is made by 
demonstration of intra-erythrocytic organisms with appropriate morphology in 
blood, lymph node, bone marrow or splenic aspirates in combination with 
compatible clinical signs (Shaws et al. 2001) and by PCR on the same samples 
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(Carli et all 2012).  Anti-protozoal therapy using imidocarb diproprionate or 
diminazene aceturate is recommended. A single injection provides sufficient 
residual activity in the majority of cases. Supportive fluid therapy is essential and 
DIC should be managed using heparin. Broad spectrum antibiotic therapy with 
enrofloxacin or cephalosporins is also recommended (Shaw et al., 2001). 
 
1.13 BABESIOSIS 
Babesia species are tick-borne apicomplexan parasites of erythrocytes that infect 
a variety of domestic and wild animals, and humans. Babesiosis in domestic cats 
is a more rare clinical infection in comparison with its canine counterpart. 
Clinical domestic feline babesiosis has mostly been reported from South Africa 
where infection is mainly due to Babesia felis, a small Babesia that causes anemia 
and icterus (Penzhorn et al., 2004; Schoeman et al., 2001). B. felis also infects 
African wild felids including lions, cheetahs and servals (Bosman et al., 2007). 
Other reports of domestic feline babesiosis have mostly been sporadic. Babesia 
cati was reported from a cat in India (Mudaliar et al., 1950) and a few cases of 
infection in domestic cats by unnamed Babesia parasites were reported in 
France, Germany, Thailand and Zimbabwe (Bourdeau, 1996; Jittapalapong and 
Jansawan, 1993; Moik and Gothe, 1997; Stewart et al., 1980). A large form 
Babesia, B. canis presentii, was described in cats from Israel (Baneth et al., 2004). 
Interestingly, the presence of Babesia species typical to dogs in domestic cats is 
detected sporadically by molecular techniques often without compelling evidence 
of clinical infection. Molecular evidence for infection by B. canis and B. microti-
like piroplasmid in cats was provided in a study from Spain and Portugal  
(Criado-Fornelio et al., 2003b). In addition, B. vogeli has been identiﬁed by 
blood smear examination and PCR in stray cats from metropolitan Bangkok, 
Thailand (Simking et al., 2010). The naturaltransmission of babesiae to vertebrate 
hosts occurs through the bite of a vector tick. Although information on some of 
the tick vectors for canine babesial species is available, very litle is known 
regarding the tick transmission of feline babesial species (Solano-Gallego,  et 
al.,).  Some species of Babesia including B. canis have been shown to be infective 
to animals only 2–3 days after tick attachment (Schein et al., 1979). Babesia spp. 
are generally highly host-specific with regard to both the transmitting tick species 
and the mammalian host. After being ingested with a blood meal, Babesia stages 
penetrate the gut epithelium of the tick, multiply and migrate to different organs 
including the tick ovary and salivary glands. Transovarial transmission from 
infected adult female ticks to their progeny occurs with large Babesia spp. And 
thus their larvae (“seed ticks”) can be an important source of infection. Female 
Dermacentor spp. generally require a period of initial feeding before Babesia 
sporozoites are available for transmission within their saliva to the dog; in male 
ticks, transmission may be more rapid as they repeatedly feed taking only small 
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amounts of blood, they perform co-feeding with females and possibly feed from 
several different hosts. Sporozoites infect erythrocytes where they differentiate 
into merozoites and divide by binary fission eventually causing cell lysis 
(ESCCAP). The pathology that Babesia inﬂicts in the host varies considerably 
with the different species and sub-species involved, and also with the host’s 
individual immune status, age, concurrent infections or illness and response to 
infection (Irwin, 2009). Haemolytic anemia and systemic inﬂammatory response 
syndrome leading to multipleorgan dysfunction syndrome account for most of 
the clinical signs observed in canine and feline babesiosis (Taboada and Lobetti, 
2006). In general, Babesia species cause a haemolytic anemia which is 
multifactorial and is the predominant clinical manifestation inducing a number 
of immune responses that may have a devastating inﬂuence (Ayoob et al., 
2010a). Haemolytic anemia can occur due to direct red blood cell lysis by 
replicating intracellular parasites which cause a combination of intravascular and 
extravascular haemolysis. A number of mechanisms are involved with red blood 
cell destruction. These include the binding of antibodies to cell surface and 
complement activation (, production of serum haemolytic factors, erythrocyte 
oxidative damage and increased red blood cell phagocytosis, creation of 
spherocytes, and a decrease in the osmotic fragility of red blood cells (Carli et al., 
2011). Intense haemolysis results in haemoglobinemia, haemoglobinuria, 
bilirubinemia and bilirubinuria. Thrombocytopenia alone is observed in many 
cases of babesiosis andmay relate to immune, splenic sequestration or 
coagulatory consumption of platelets from haemolytic or vascular injury. 006). 
Tissue hypoxia is an important contributor to many of the clinical signs caused 
by the most Babesia spp.(Solano-Gallego et al., 2011). Babesia infection in cats is 
associated with anorexia, lethargy, anemia and icterus. Information on the 
clinical manifestations of domestic feline babesiosis is limited mostly to 
publications on B. felis infection in South Africa (Ayoob et al., 2010b; Penzhorn 
et al., 2004; Schoeman et al., 2001). In a study on B. felis that included 56 cats 
(Schoeman et al., 2001), 80% were less than 3 years old and there was no speciﬁc 
breed or gender predilection. Most cats were anorectic and lethargic. Macrocytic 
hypochromic regenerative anemia was present in the majority of infected cats. 
Hyperbilirubinemia was present in 86% of the cats and alanine aminotransferase 
activity was elevated in 89%. Thirty two percent of the cats were concurrently 
infected with feline leukemia virus (FeLV) and 14% with feline 
immunodeﬁciency virus (FIV). Babesia canis presentii infection in a cat from 
Israel co-infected with FIV and Candidatus Mycoplasma haemominutum was 
accompanied by fever, icterus, moderate anemia and thrombocytopenia which 
resolved following anti-babesial therapy (Baneth et al., 2004). The only systemic 
abnormality recordedina catwith B. cati infection in India was fever (Mudaliar et 
al., 1950). Diagnosis is made by demonstration of intraerythrocytic protozoal 
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organisms with appropriate morphology in blood, lymph node, bone marrow or 
splenic aspirates in combination with compatible clinical signs. Sensitivity is 
limited by low-level parasitaemia in chronic cases or where prevalence is low 
(Shaw et al., 2001). The polymerase chain reaction (PCR) is a sensitive and 
speciﬁc diagnostic techniquewhich is frequently employed for the diagnosis of 
babesiosis. It is particularly useful for detection of infection in animals with a 
low parasitaemia levels and for speciation of parasites (Solano-Gallego et al., 
2011.  No serological tests are routinely available for cats (Shaw). The drug most 
commonly recommended for treatment of babesiosis in cats caused by B. felis  is 
the antimalarial, primiquine phosphate  at the dosage of 0.5 mg/kg PO sid for 3 
days (more than 1 mg/kg is lethal in cast) ; the response to the treatment is 
usually good but there can be occasional to frequent relapses (Ayoob et al. 
2010b, Penzhorn et al. 2004); feline babesiosis caused by B. canis presentii can 
be treated with Imidocarb dipropionate (2.5–3mg/kg IM) with a good response 
(Baneth et al. 2004). Blood transfusions are rarely required (Shaw et al., 2001).  
 
 
1.14 LEISHMANIOSIS  
Leishmaniosis is caused by an intracellular protozoan parasite of the genus 
Leishmania and is transmitted by sandflies. L.  infantum infection is common in 
dogs in endemic areas of Europe, the Middle East and many tropical and 
subtropical areas of the world and causes serious systemic and cutaneous disease 
in susceptible animals (Shaw et al., 2001). In contrast to dogs, natural infection 
and clinical disease in domestic cats caused by Leishmania species appear to be 
rare. Clinical disease and subclinical infections have been reported sporadically in 
the following regions and countries where canine leishmaniosis is endemic: 
southern Europe; North Africa, Iraq; Iran; central and South America (Solano-
Gallego and G. Baneth 2013).   Whether the low prevalence of infection/disease 
in endemic areas is due to under-reporting or to the fact that cats have a high 
degree of natural resistance is unknown. However, cases of feline systemic 
clinical disease and asymptomatic infection due to L infantum and other species 
are reported (Passos et al.,  1996, Ozon et al.,  1998, Hervas et al., 1999) and wild 
cats have been incriminated as reservoirs for leishmaniosis in endemic 
Mediterranean countries (Shaw et al., 2011). Clinical leishmaniosis in domestic 
cats has been reported to involve L. infantum  in Europe and Brazil; L. Mexicana 
in Texas; L. venezuelensis in Venezuela, and L. braziliensis and L. amazonensis 
in Braszil (Solano-Gallego and G. Baneth, 2013). Animals living in an endemic 
area can develop specific antibodies against leishmania and  they can be 
evidentiated by means of IFAT. The antibody titers appear to be lower in 
affected cats than in dogs, even if the number of clinical cases is very scanty 
(Mancianti F 2004, Barnes et al 1993). Serologic and PCR surveys of cat 
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population in canine leishmaniosis-endemic regions in southern Europe and 
Middle East indicate that feline infection is more widespread than clinical 
disease. Epidemiologic studies have described seroprevalence rates ranging from 
0,9% to 30%.  The true role of cat as reservoir of L. infantum infaction remains 
unclear, even if transmission of  L. infantum to sandflies (P. perniciosus) from 
chronically infected cat under experimental condition has been reported (Solano-
Gallego and G. Baneth, et al., 2013). Cutaneous leishmaniasis is the more 
frequent form in cats and it was reported from several countries. Typical signs 
include nodular to ulcer or crusty lesions on the nose, lips, ears, eyelids, diffuse 
areas of alopecia and granulomatous dermatitis: clinical signs of cutaneous FL 
are unspecific and in endemic area this infection must be taken into account 
(Mancianti F 2004, Barnes et al 1993) . Visceral leishmaniasis with  involvement 
of spleen, liver, bone marrow, lymph node, uvea, and kidney have been less 
commonly described and are thought to be associated with immunosuppression 
caused by leukemia virus and immunodeficiency virus infections or other 
concomitant diseases (Solano-Gallego et al.,2013): liver and spleen are interested, 
with lymph nodes and kidney (Mancianti F.2004) in association with jaundice, 
vomiting, hepatomegaly, splenomegaly, lymphadenomegaly, membranous 
glomerulonephritis and granulomatous gastroenteritis (Ozon et al 1998).As in 
dogs, hyperproteineimia with hypergammaglobulinemia is a common finding in 
feline leishmaniosis. (L. Solano-Gallego et al.,2013) Untreated affected cats can 
frequently die. Some of the affected cats were FIV and/or FeLV positive and 
these viroses such as stress may induce an impaired cellular immune response. 
However the resistance of the cat to leishmania infection probably depends on 
genetic factors, not strictly related to cell mediated immunity (Mancianti F. 
2004). Presumptive diagnosis is most commonly made by the demonstration of 
protozoal organisms in tissue biopsy specimens using both light and electron 
microscopic examination or by the demonstration of specific antibodies against 
leishmania using IHAT, Western blot or IFAT (Mancianti F 2004, Shaw et al. 
2001). PCR on blood samples or better on bone marrow or lynph node aspirates 
offers a sensitive and specific diagnostic tool for this disease (Mancianti F 2004, 
Shaw et al, 2001,. Solano-Gallego et al., 2013).   
Very little published information is available on drug therapy for feline 
lieshmaniasis. One cat in Spain with primarily cutaneous lesions was treated with 
5 mg/kg of meglumine antimoniate subcutaneously combined with 10 mg/kg 
ketoconazole orally. A 4-week course of combine therapy was repeated three 
times, with 10 days without therapy between each course, and resulted in the 
resolution of cutaneous lesions. Successful treatment of cats with clinical 
improvement was achieved in the majority of cases with 5 to 10 mg/kg 
allopurinol, given twice daily. Cats with disseminated of infection required longer 
allopurinol treatment of at least 6 months in comparison to the shorter course 
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reported beneficial for cats with only cutaneous lesions. Topical treatment of 
cutaneous L. Mexicana infection in a cat with clotrimazole and subsequently with 
paromomycin did not improve the dermal lesions (Solano-Gallegoet al. 2013). 
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Authors Year  Journal  Number 
of tested 
cats  
Characteristics of 
feline population  
Methods  Location  Prevalence   Notes 
ITALY         
Poli  
et al  
2002 Veterinary 
Parasitology 
106 (2002) 
181–191 
 
110  Owned  
apparently healthy cats 
submitted to 
practitioners for 
vaccination program 
 
IFAT Italy (Liguria 
and Tuscany) 
 
1/110 (0.9%) Titre 1:160 
Vita et al  2005 Veterinary 
Research 
Communicatio
ns, 29(Suppl. 
2) (2005) 319–
321 
 
203  IFAT  central Italy 
(Abruzzo) 
 
33 of 203 cats 
tested (16.3%);  
 
all samples were initially tested at a 
dilution of 1:40;  
20 of these 33 1 a 40; ten cats a 
titer of 1:80, two cats a titer 
of 1:160, and one a titer of 1:320;  
 
Pennisi  2004 
 
Veterinary 
Research 
Communicatio
ns, 28 (2004) 
363–366 
 
4 
 
Four domestic cats 
with dermatological 
signs 
 
microscopic 
(smears from 
cutaneous 
ulcers and 
cysts, and 
from lymph 
node needle-
aspiration) 
and 
serological 
investigation
s (IFAT) 
Italy 
(Messina 
district) 
 
4/4; 100% 
 
 
Pennisi  
et al  
1998 Proceeding 
SiSVet  
93  57 FIV+ stray and 
owned cats and 36 
FIV- stray cats  
IFAT Sicily  55/93 (59%) 
40/57 FIV+ 
(70%) and 
14/36 FIV- 
Statistical association between 
FIV+ and FeL + and FIV+ and 
value of L. infatum IFAT 
(higher) 
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Pennisi  
et al  
2000 Proceeding 
Sisvet  
89  Owned cats  IFAT + 
PCR on 
blood 
Sicily  54/89 PCR+ 
(61%), IFAT+ 
68% 
 
Boari  
et al  
 Proceeding 
Terrasini  
288 Mainly stray cats  IFAT Abruzzo 36/288 
(12.5%) 
 
         
EUROPE         
SPAIN         
Solano-
Gallego  
et al  
2007 Am. J. Trop. 
Med. Hyg., 
76(4), 2007, 
pp. 676–680 
 
455 445 cats living in 
ecoregions around 
the Northwestern 
Mediterranean basin; 
Barcelona 
(N   390), Tarragona 
(N   12), and the 
island of Mallorca 
(N   43). Clinical 
veterinarians 
collected all samples. 
Samples from 
Barcelona had two 
different origins: 255 
stray 
cats from the animal 
pound of Barcelona 
and 135 cats 
examined 
at the Veterinary 
Teaching Hospital 
of the Universitat 
Autònoma de 
Barcelona. 
ELISA+WB Spain 
(Northeaster
n Iberian 
Peninsula 
and Balearic 
Islands: 
Barcelona, 
Tarragona, 
Mallorca) 
5.3-6.3% 
Seroprevalence 
by ELISA-prot 
A was 6.29%, 
and that by 
ELISA-IgG 
was 5.25%. 
There 
were also 
13.03% and 
6.56% of 
uncertain results 
for ELISAprot 
A and ELISA-
IgG, 
respectively 
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Martin-
Sanchez  
et al  
2007 Veterinary 
Parasitology 
145 (2007) 
267–273 
 
183 (+28 
control 
cats from 
non 
endemic 
area)  
Owned cats;  
183 cats from endemic 
area Southern Spain; 
28 cats from the 
North of France 
(Strasbourg area) 
 
 
 
IFAT+PCR 
on blood. 
 In PCR 
positive 
cats in which 
it was possible 
to obtain 
another 
sample 
of blood, 
bone marrow 
and/or lymph 
node aspirate 
in a 
period of 15–
20 days, this 
was cultured 
and Giemsa 
stained 
 
Southern 
Spain  
47/183 
(25.7%) PCR 
IFAT: 60.0%  
Ab titers  > 10; 
28.3% with ab 
titer ≥40; 6.1% 
of cats 
presented an Ab  
titers > o  = 
160: 8 cats had 
an antibody titer 
= 160, 1 with 
Ab = 640, 1 
with Ab = 1280, 
and 1with Ab = 
5120 
Seropositive with Ab titre ≥10. 
The highest proportion of 
positive PCRs (31.6%) was 
observed in cats with an Ab 
titer=20. By the contrast, the 
population with a high Ab titer 
(≥160) is the one that present 
the smallest proportion of  
positive PCRs (18.2%); 7 cats 
with a positive PCR were tested by 
culture and microscopic 
examination of Giemsa-stained 
samples. In 3 of them, amastigotes 
were observed in 
the stains. No culture was positive. 
 
Ayllon  
et al 
2012 
 
VECTOR-
BORNE AND 
ZOONOTIC 
DISEASES 
Volume 12, 
Number 2, 
2012 
 
680 680 (539 (79.3% of 
total) client-owned 
cats ; 141 (20.7% of 
total) 
stray cats from Madrid 
area) 
 
IFAT+PCR 
on blood 
Central 
Spain 
(Madrid) 
IFAT: stray cats 
6.4% (n = 9); 
client-owned 
cats 3%(n = 16); 
all cats 25/680 
3.7%.  
PCR: 0.6%;  4 
/680; 3 were 
client-owned 
cats, and 1 was 
a stray cat 
IFA (1:50) 
 
T Ayllon et al 
 
2008 
 
Animal 
Biodiversity 
and Emerging 
233 
 
cats attended at the 
Veterinary Teaching 
Hospital in Madrid 
IFAT+PCR Central Spain 
(Madrid) 
 
1.29% 3/233 
with a titer > 
1:100; 2 of 
IFAT (1:100 cut-of titer) 
50 
 
Diseases: Ann. 
N.Y. Acad. Sci. 
1149: 361–364 
(2008) 
 
for different 
medical or surgical 
reasons 
3 seropositive 
cats had an 
antibody titer 
= 1:400, 1 had 
an antibody 
titer = 1:100. 
 7 cats had a 
titer = 1:50. 
Considering all 
the positive 
cats the 
prevalence was 
4.29%. 
PCR: 1/233 
(0.43%)  
M D Tabar et 
al 
 
2008 Veterinary 
Parasitology 
151 (2008) 
332–336 
 
100 
 
cats PCR 
 
Barcelona 
area; Spain 
 
3% 
 
 
K Sherry et al 
 
2011 
 
VECTOR-
BORNE AND 
ZOONOTIC 
DISEASES 
Volume 11, 
Number 3, 
2011 
 
105 
 
cats living outdoors in 
two shelters 
 
ELISA 
 
Spain (Ibiza) 
 
13.2% 
 
Sera were tested for IgG antibodies 
against L. infantum, Toxoplasma 
gondii, and feline 
immunodeficiency virus (FIV) and 
for the detection of feline leukemia 
virus (FeLV) p27 antigen by 
enzymelinked immunosorbent 
assay (ELISA) 
 
PORTUGA
L  
        
Duarte  
et al  
2010 Journal of 
Feline 
180 Stray cats IFAT Lisbon  0.6% Cut-off 1/40 
51 
 
Medicine and 
Surgery 
(2010) 12, 
441-446 
Maia  
et al  
2008 VECTOR-
BORNE AND 
ZOONOTIC 
DISEASES 
Volume 8, 
Number 4, 
2008; 555-559 
 
23 Stray cats PCR on 
blood (IFAT 
on 20 cats) 
Lisbon  7/23 (30.4%) 
PCR 
4/20 IFAT. 
3 cats 
presented an 
IFAT titer of 
1:2 and 1 cat 
presented a 
titer of 1:16. In 
3 of these 4 
cats, PCR and 
real-time PCR 
were positive. 
The serum obtained from each 
animal was diluted from 1/2 to 
1/64. 
 
Cardoso  
et al  
2010 Veterinary 
Parasitology 
174 (2010) 37–
42 
 
316 Domestic cats DAT+ELIS
A 
Northern 
Portugal  
6 positive to 
DAT; 9 
positive to 
ELISA; The 
overall 
Seroprevalence 
was 2.8% 
 
Maia  
et al  
2010 Veterinary 
Parasitology 
174 (2010) 
336–340 
 
142 130 client-owned 
cats+12 stray cats 
IFAT+PCR 
on blood 
 the Lisbon 
metropolitan 
area, Portugal 
 
20.3% PCR 
(28/138) 
1/76 IFAT 
The serum obtained from each 
animal was diluted from 1/2 to 
1/256 
 
FRANCE         
Bez  1992 PHD tesis 
Ecole Vet 
174  IFAT  0.6%  
52 
 
Lyon 
Marechal  1993 PHD tesis 
Ecole Vet 
Lyon 
110  IFAT, WB, 
ELISA 
 2.7%  
GREECE         
Diakou et al  2009 Journal of 
Feline 
Medicine and 
Surgery (2009) 
11, 728e730 
 
284 stray adult cats, living 
in the major area of 
Thessaloniki 
(Northern Greece) 
 
IgG ELISA the major 
area of 
Thessaloniki,
Northern 
Greece 
11 (3.87%) 
 
 
AFRICA         
Michael et al  1982 J Egypt Soc 
Parasitol. 1982 Jun;
12(1):283-6. 
80  Stray cats IHA Egypt  3.75%  
Morsy et al  1988 J Egyptian 
Soc Parasitol 
28 Stray cats  IHA Egypt  3.6%  
Morsy and El 
Seoud 
1994 J Egypt Soc 
Parasitol. 1994 Apr;
24(1):199-204. 
60 pet and stray cats IHA Egypt  3.3% Microscopic confirmation  
SOUTH 
AMERICA  
        
Simoes-
Mattos et al  
2001 Ciencia 
Animal  
84 Stray cats ELISA Brazil  10.7%  
Vides et al  2011 Veterinary 
Parasitology 
178 (2011) 22–
28 
 
55 55 cats with 
dermatologic lesions 
from two major 
animal shelters of 
Aracatuba, 
Southeastern Brazil 
 
Citology, 
ELISA, 
IFAT, PCR; 
immunohisto
chemistry 
(IHC) in skin 
lesions of all 
cats 
Aracatuba, 
Southeastern  
Brazil 
VL was 
diagnosed in 
27/55 (49.1%) 
cats with 
dermatological 
problems. 
10/27 (37.0%) 
cats (citology of 
lymphoid);  
14/27 (51.9%) 
ELISA;  
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6/27 (22.2%) 
IFAT;  
5/27 (18.5%) 
both IFAT and 
ELISA; 
IHC positive 
9/27 (33.3%) 
cats; 5/27 
(18.5%) were 
positive only for 
IHC; 3/52 
(5.76%) 
positive both 
IHC and PCR 
on tissue 
Longoni et al  2012 Comparative 
immunol 
microbiol 
infect 
diseases  
95 Stray cats  ELISA+WB Mexico   
Dourado-
Coehlo et al 
2011 Parasitol Res 
(2011) 
109:1009–1013 
 
70  Cats form urban and 
rural area  
ELISA+IFA
T 
Andradina 
Municipality, 
São Paulo 
State, Brazil 
 
4.2% ELISA 
0% IFAT 
Leishmania chagasi  
Costa et al  2010 Brazilian 
Journal of 
Veterinary 
Research and 
Animal 
Science  Volum
e: 47   Issue: 3   
Pages: 213-
200 cats Citology+EL
ISA 
Brazil  14.5% (31/200) of 
the feline 
population studied, 
with 4% (8/200) of 
positivity by 
parasitological 
diagnosis and 11.5% 
(23/200) by 
serology 
L. infantum chagasi 
54 
 
217  
Coehlo et al  2011 Veterinary 
Parasitology 
176 (2011) 
281–282 
 
52 cats sent by their 
owners 
to the Center for 
Zoonosis Control at 
Andradina 
Municipality, São 
Paulo State, Brazil, for 
euthanasia 
 
Citology on 
imprints of 
poplited 
lymph node, 
bone 
marrow and 
spleen. 
The samples 
positive at 
citology were 
subjected to 
PCR 
Andradina 
Municipality, 
São Paulo 
State, Brazil 
 
5.76% (3/52) 
 
L. infantum chagasi 
USA          
R Wells et al 2012 Veterinary 
Record 2012 
171: 654 
1 PCR imported 
from South 
Africa three 
weeks 
beforehand 
USA 100%  
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1.15 HEPATOZOONOSIS 
Hepatozoonosis is a tick-transmitted, protozoal disease caused by species of the 
intraleucocytic parasite, Hepatozoon. Hepatozoonosis of domestic cats has been 
reported from several countries including: India, South Africa, Nigeria, the USA, 
Brazil, Israel, Spain and France (Baneth, 2011; Patton, 1908, Leeflang and 
Ilemobade, 1977, Van Amstel, 1979, Ewing, 1977, Perez et al., 2004, Klopfer et 
al., 1973, Tabar et al., 2008 and Beaufils et al., 1998). It has mostly been reported 
from regions where canine infection is also present. The species of Hepatozoon 
that infect cats has not been definitely identified and it is currently unknown if 
only a single species is found in cats and whether it is similar to species described 
in other animals. Some studies have referred toHepatozoon felis as the species 
of Hepatozoon infecting felids (Tabar et al., 2008) whereas other authors have 
determined that H. canis is responsible for feline hepatozoonosis ( Wenyon, 
1926 and Jittapalapong et al., 2006). Unlike other ticktransmitted diseases, 
infection with Hepatozoon in dogs occurs by ingestion of infected 
Rhipicephalus sanguineus ticks rather than by tick bites, and cats are presumed 
to be infected by the same route, even if the vectors of feline hepatozoonosis are 
not known. As in dogs with H canis infection, a characteristic clinical syndrome 
in cats associated with hepatozoonosis is difficult to define. Feline 
hepatozoonosis is associated with infection of muscle tissues. Hepatozoon 
meronts have been identified in the myocardium and skeletal muscles of 
domestic cats and wild felids with hepatozoonosis ( Klopfer et al., 1973, Beaufils 
et al., 1998 and Kubo et al., 2006), and elevated activities of the muscle enzyme 
creatinine kinase were found in the majority of cats with hepatozoonosis in a 
retrospective study of this disease (Baneth et al., 1998). The level of parasitaemia 
is usually low in cats with less than 1% of the neutrophils containing gamonts. 
Co-infection with FIV, FeLV and Haemobartonella felis has been reported with 
feline hepatozoonosis (Baneth et al 1998). Diagnosis as in the other arthropod-
borne protozoal infections, is by demonstration of intra-leucocytic organisms 
with characteristic morphology in peripheral blood or bone marrow smears. 
Response to therapy with doxycycline for 14–21 days has been recommended 
(Baneth et al 1995a). 
 
 
 
1.16 STRATEGY OF CONTROL 
Vector control 
The importance of prophylactic flea control in the management of bartonellosis 
has been demonstrated (Chomel et al 1996, Kordick & Breitschwerdt 1998; 
Shaw 2001)). This emerging zoonosis is an important reason to maintain routine. 
prophylactic flea control measures in cats and safe, effective, residual insecticides 
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are now available for use (Insecticides/Acaricides: Fipronil, Selamectina, 
Nitenpyram, Imidocloprid. Insect growth regulators: Fipronil/Methoprene, 
Lufenuron, Pyriproxifen). Control measures should combine both adulticide and 
insect development inhibitors that are licensed for use in cats. Tick control in 
cats is also recommended in endemic areas. However, there is a marked deficit 
of literature concerning the efficacy of acaricides for tick infestation in cats. This 
may reflect the technical difficulties involved in performing such studies. One 
obvious problem lies in establishing large enough patent tick infestations in both 
control and treated groups to ensure reliable estimates of efficacy. A further 
problem lies in toxicity of pyrethroids in cats which limit their use as acaricides 
in this species. Fipronil is the only acaricide which has been extensively 
investigated as an acaricide for use in 
cats (Wiedemann 2000; Shaw 2001). 
It is different for feral cats: free-roaming cats are often untreated against 
ectoparasites. Because feral cats should only be handled after they are 
anesthetized, treatment of parasites at the time of sterilizazion is limited to 
topical and injectable products. Products selection should be based on safety, 
spectrum, cost and ease of treatment. The advantage of a single treatment for 
parasites at the time of surgery is uncertain.  However cats with heavy flea 
infestations can be sprayed with cat-safe flea spray before surgical preparation 
for immediate control of fleas. Another option is rectal administration of 
nitempyram. There are also numerous topical products available for flea control 
with longer duration activity. Many topical products have activity against 
intestinal parasites and ear mites. Products with efficacy against fleas, 
roundworms, and hookworms are likely to provide the greatest health benefit 
during feral cat-TNR programs. Avermectina drugs should be avoided in young 
debilitated kittens, because neurologic side effects have been reported in this 
group. Parasiticides can be mixed in food for ongoing treatment, but this is 
usually not practical such as roundworms and hookworms cannot be controlled, 
similar to the case for wildlife species (Levy,).  
Vaccination 
The development of vaccination programmes for control of arthropod-borne 
infections in cats would benefit both feline and human health. However, there 
are intrinsic problems with producing vaccines against a group of organisms that 
can readily evade and manipulate the host immunity Moreover, vaccine 
development requires detailed knowledge of the nature of the target species 
immune response to immunodominant epitopes, and such studies are lacking for 
these feline micro-parasites. Of the diseases reviewed here, feline vaccination has 
been proposed only for the control of human CSD (Shaws 2001).  
Demographic control of feral cats 
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Free-roaming animals constitute a major reservoir for infectious diseases in dogs 
and cats in general population. Trapping, neutering and returning animals to 
their environment has been done for free-roaming cats in many areas (Greene et 
al., 2013). Same programs are quite elaborated, including extensive veterinary 
care, surveillance for infectious diseases, colony registration, monitoring and 
adoption of tame cats; others focus solely on sterilization. Whereas most 
programs are run by small volunteer groups dependent on donations for 
operating costs, a growing number are operated with public funds by municipal 
animal control agencies with the belief that sterilization is ultimately more 
efficient and cost-effective than ongoing extermination (Levy 2013).
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2. COLONY STRAY CATS OF MILAN 
 
Worldwide domestic and feral cat (Felis catus) numbers have increased. 
Concerns regarding high populations of feral cats in urban areas include wildlife 
predation, public nuisance and disease (Jones AL et al., 2011). In fact feral cats 
can serve as a direct or indirect source of infection for outdoor pet cats 
(Stojanovic V et al., 2011) and for their owners. Thus, feline urban populations 
are recognized as public health hazards (Mendes-de Almeida et al., 2011). 
Debate about the actual impact of free-roaming cats on the environment, on 
nonfelid and felid wildlife, on domestic feline health, ad as a reservoir of both 
feline and zoonotic diseases is going. This debate is often emotional, fueled 
largely by lack of sound scientific data on which to form credible conclusions. 
Separating the impacts of owned cats that roam outdoors from those of 
unowned ones is also difficult. Increasing social awareness towards unowned 
free-roaming cats has resulted in a new concept of “community” or “village” 
cats. This terminology describes how cats are regarded in much of the world. In 
addition to cat that clearly have an identified owner and residence, most 
communities are also populated by colonies of free roaming cats occupying a 
wide spectrum of socialization level and interactions with human society. This 
cats are “owned” by the community and the community is their “home” (Levy, 
2013). 
In the territory of the city of Milan there are a lot of these “community cats” 
living in small colonies in close association with human activities such as schools, 
restaurants and neighborhoods, considered as an integral component of the 
overall cat population. They are managed by volunteers who take care of their 
nutrition, their census and their capture during TNR (trap-neuter-return) 
programs implemented by local health authority (ASL). 
In Milan there are more than 450 cats colonies, but is difficult to estimate the 
real number of feral cats. These colony stray cats are protected by national, 
regional and municipal laws and regulations: usually they can live free-roaming 
and cannot be moved from the places they are established. Their capture is 
allowed only for sterilization and health care, but they have to return them to 
their colonies.   
The feral cats can carry the same diseases as pet cats, but the risk of infection 
transmission is affected by factors such as the cats proximity and relationship to 
humans and other animals (particularly owned cats), route of transmission, 
pathogen persistence in environment, and predation. Currently, there are sparse 
data available to quantify the risks contributed by feral cats compared to that of 
pet cats. Cetrain conditions, such as rabies, bite wounds, bartonellosis, zoonotic 
and non zoonotic enteropathogens, arthropods and arthropod-borne diseases 
and feline infections such as feline immunodeficiency virus (FIV) and feline 
62 
 
leukemia virus (FeLV) are of interest to public and/or feline health. For these 
reasons we have concuted studies on the prevalence of vector-borne diseases in 
colony stray cats of Milan city” (J K Levy, Chapter 98, Greene 4TH Ed) . 
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Purpose of the work.  
To assess the prevalence of leishmaniosis in a large representative sample of 
stray cats from this non-endemic area, and to analyze 
the results according to clinical, laboratory and infectious data. 
 
Materials and used methods.  
Blood samples were collected from 233 European shorthair stray cats from 
urban colonies in Milan, northern Italy, during a trap-neuter-release (TNR) 
program. The following data were recorded: sex (n=233), age (n=233), body 
condition score (n=215), area of colony of provenance i.e. one of the seven 
municipalities of Milan (n=233), health status based on physical examination 
(n=233), and dermatological evaluation (n=121), complete blood cell count 
(n=127), antibodies to FIV relative to the gp40 and p24 FIV antigens, the FeLV 
p27 antigen (n=137), and Toxoplasma gondii IgG antibodies (n=79). The 
presence of anti-L. infantum antibodies was measured by an indirect 
immunofluorescence antibody test (IFAT) performed according to the 
recommendations of OIE using MHOM/IT/80/IPT1 as a whole-parasite 
antigen fixed on multispot slides and fluorescently-labeled anti-feline gamma as 
conjugate. L. infantum DNA was amplified from 200 μl of whole blood by real-
time PCR. The target for amplification was a 116-bp fragment in the constant 
region of the kDNA minicircle. 
The primers used were QLK2-UP 5’-GGCGTTCTGCGAAAACCG-3’ and 
QLK2-DOWN 5’-AAAATGGCATTTTCGGGCC-3’; the TaqMan probes were 
Q Leish Probe 2 and 5’-FAM TGGGTGCAGAAATCCCGTTCA-3’- Black 
Hole. Factors associated with the L. infantum positivity were considered 
statistically significant when P<0.05. 
Outcomes.  
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The serology test for L. infantum showed that 25.3% (59/233) of the cats had L. 
infantum seroreactivity, 38 (16.3%) had antibody titers of 1:40, 15 (6.4%) had 
titers of 1:80 and 6 (2.6%) had antibody titers of 1:160. 
All blood samples tested using real time PCR were negative for the presence of 
L. infantum DNA. Only FIV seropositive status was statistically associated with 
seroreactivity to L. infantum (multivariate logistic regression: P=0.0098 and OR 
= 7.34 (95%CI=1.96 to 27.59). 
Conclusions.  
This study is the first epidemiological investigation of feline Leishmania 
infection in the metropolitan area of Milan, which is a non-endemicarea for 
leishmaniosis. Our results were surprising, since no autochthonous canine cases 
of leishmaniosis have ever been reported in this region in northern Italy. In 
countries in southern Europe where leishmaniasis is endemic, serological 
investigations performed in feline populations using different techniques have 
revealed prevalence rates that range from less than 1% to more than 60%.1 As 
here, previous epidemiological studies have used IFAT to detect antibodies to 
Leishmania spp. in cats.1,2,3,4 
None of the peripheral blood samples we examined using real-time PCR were 
positive for parasite DNA. PCR has been used previously by others, either alone 
or in combination with serology, as in our study, to assess the prevalence of 
feline Leishmania infection. Blood is not the best specimen for PCR diagnosis of 
leishmaniasis. Specifically, PCR performed on canine blood has lower sensitivity, 
specificity and positive and negative predictive values compared to PCR 
performed on canine lymph node aspirates, 5 and this may be true for samples 
from cats as well. However, blood sampling is less invasive and is easy to 
perform, particularly for epidemiological studies involving numerous subjects, as 
in our survey. In addition, in many previous studies, L. infantum DNA was 
found in whole blood samples from cats.1,2,3,4 
Our survey may be an overestimation due to the possibility of IFAT 
crossreactivity between L. infantum and other pathogens, possible on some 
serologic tests, especially those that use a whole-parasite antigen, as we did here. 
This has been demonstrated in dogs in that IFAT cross-reactivity has been 
reported for L. infantum and Trypanosoma cruzi, Leishmania braziliensis and 
Ehrlichia canis infection.6 
There was no significant correlation between T. gondii-positivity and L. 
infantum- positivity in our study. This may suggest a lack of cross-reactivity with 
Toxoplasma parasites. 
Additional studies that include parasite isolation are needed to clarify our 
findings on feline leishmaniasis in this geographic area. 
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Abstract  
 Feline vector-borne diseases are caused by a wide range of pathogens, 
which are transmitted by arthropods. Many of these infections have zoonotic 
implications and feral cats may potentially act as sentinels of human and pet 
health. The present study investigated the prevalence of vector-borne infections 
in feral colony cats in the city of Milan in northern Italy. Blood samples from 
260 feral cats were evaluated, with conventional PCR, for the presence of DNA 
associated with hemoplasmas (Mycoplasma haemofelis and Mycoplasma 
haemominutum), Rickettsia spp., Anaplasma phagocytophilum, Ehrlichia spp. 
and Babesia microti. Odd ratios (OR) were calculated to identify risk factors for 
infection with vector-borne pathogens. Positive PCR was found in 156 out of 
260 subjects (60%), with a prevalence of 33.1% for hemoplasmas, 31.9% for 
Rickettsia spp., 17.7% for A. phagocytophilum , 6.7% for Ehrlichia spp. (out of 
30 samples), and 1.2% for B. microti spp (out of 168 samples). Statistical analysis 
revealed a correlation between infections with Rickettsia spp. and hemoplasmas 
(OR=1.95, P=0.02). Additionally, Rickettsia spp. infection was associated with 
ocular infection (OR=2.21, P=0.02). We conclude that vector-borne infections, 
including zoonotic diseases, are present in feral cats of Milan. Thus, domestic 
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cats exposed to the outdoors should be routinely monitored and treated for 
ectoparasites to minimize disease onset and potential transmission of zoonotic 
agents to humans. Moreover, as these vector-borne infections are transmitted 
through blood, feline blood donors from this area should be screened by PCR. 
 
Keywords: feral cats, northern Italy, PCR, vector-borne infection, Mycoplasma 
haemofelis, Mycoplasma haemominutum, haemoplasmas, Rickettsia spp., 
Anaplasma phagocytophilum, Ehrlichia spp., Babesia microti 
 
Introduction  
 Feline vector-borne diseases (FVBDs) are an emerging problem 
worldwide due to their frequency and morbidity. Furthermore, most cases of 
FVBDs are zoonotic and feral cats may potentially serve as sentinels for human 
infection (Kile et al, 2005). FVBDs, such as rickettsiosis, anaplasmosis, 
ehrlichiosis, and babesiosis, are caused by diverse pathogens transmitted by 
arthropod vectors, particularly fleas and ticks (Birkenheuer 2012; Greene, Kidd 
and Breitschwerdt 2012; Lappin and Breitschwerdt 2012; Lappin and 
Breithschwerdt 2012; Messick and Harvey 2012). 
 Free-roaming feral cats are a public health concern in urban and rural 
areas of Italy (Slater et al, 2008). However, the environmental and medical 
impact of free-roaming cats is not fully appreciated since scientific data on these 
populations are lacking. Feral cats are predisposed to FVBDs because they live 
outdoors, have constant exposure to ticks and fleas, and prey on urban wildlife 
(such as small rodents) that harbor pathogens (Bown et al, 2003; Beck 2010). 
Additionally, free-roaming cats are often neither monitored nor treated for 
vector-borne pathogens. Although several studies worldwide have reported on 
the epidemiology and emergence of FVBDs (Ebani and Andreani 2002; Aguirre 
2004; Vita 2005; Solano-Gallego 2006; Lappin 2006; Hackett 2006; Billeter 2007; 
Tabar 2008; Gentilini 2009; Barrs 2010; Roura 2010; Bennett 2011; Ayllon 2012), 
only a few studies have focused on feral colony cats (Luria 2004; Ehberhardt 
2006; Kamrani 2008; Juvet 2010; Simking 2010) and, in particular, no studies 
exist on the feral cats of northern Italy.  
 Identification and epidemiological surveillance of the various zoonotic 
diseases in cats may advance the development and implementation of protective 
measures by national and regional agencies. Notably, some etiological agents of 
FVBDs can directly be transmitted through blood (Gary et al, 2006). With 
advances in therapeutics, administration of whole blood or blood components is 
becoming more common in feline medicine. Our knowledge on the prevalence 
of blood transmitted pathogens in cats would provide useful information for 
evaluating the risks associated with transmission of blood-borne infections when 
cats are potential blood donors. Therefore, an understanding of the prevalence 
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of FVBDs would used to limit the spread of zoonotic diseases in feline 
populations. The present study evaluated the prevalence of selected vector-borne 
agents in feral colony cats of Milan and identified possible risk factors for these 
infections.  
 
 
Materials and methods 
Sample population and data collection 
 During a 2-year collection period (January 2008 to January 2010), blood 
samples were taken from 260 feral cats from urban colonies in Milan (northern 
Italy), under a trap-neuter-release (TNR) program approved by the local 
authority of the city council. The program was conducted as previously 
described (Spada et al 2012, 2013). 
 The cats (n=260) were collected from eight zones of Milan including 3 
from zone 1 (1.2%), 11 from zone 2 (4.2%), 108 from zone 4 (41.5%), 12 from 
zone 5 (4.6%), 27 from zone 6 (10.4%), 55 from zone 7 (21.2%), 22 from zone 8 
(8.5%), and 22 from zone 9 (8.5%). All the cats were of Domestic Shorthair 
breed. Their age distribution, estimated by dentition, included 118 (45.4%) 
kittens (≤ 6 months) and 142 (54.6%) adult cats (>6 months). The group 
consisted of 90 males (34.6%) and 170 females (65.4%). The Body Condition 
Score (BCS) was recorded for 243 cats (LaFlamme et al, 1994) with a median 
score of 4.3 ± 0.73 (range 2-8 out of 9). Moreover, 225 cats (92.6%) had a BCS 
score range of 4-6, indicating normal weight. Only 18 (7.4%) cats were 
underweight (BCS = 1-3).  
 Health evaluation, based on clinical examinations, of the study group 
revealed 72 (27.7%) healthy cats and 188 (72.3%) unhealthy cats. In unhealthy 
cats, clinical abnormalities included enlarged lymph nodes (n=133, 51.2%), pale 
mucous membranes (n=14, 5.4%), stomatitis (n=101, 38.8%), signs of 
respiratory tract infection (n=22, 8.5%), and signs of ocular infection (n=40, 
15.4%). The cats were not systematically examined for the presence of ticks or 
fleas and so the rates of ectoparasitism were not recorded. 
 
Hematological and serological analyses 
 While the cats were anesthetized, blood samples were collected aseptically 
from the jugular vein and placed in EDTA-treated tubes and in serum separator 
tubes. Within 24 h of sample collection, EDTA-anticoagulated blood was 
evaluated for complete blood count (CBC, n=150) using the ADVIA 120 
System (Siemens Healthcare Diagnostics, Milan, Italy). Median hematocrit was 
25.2% (range 13-38), the median white cell count was 10.770 x 109/l (range 
1.516-23.240) and the median thrombocyte count was 374 x109/l (range 90-
800). We detected anemia (Ht <24%) in 69/150 (46.0%) cats, leukopenia (WBC 
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<10,570/μL) in 14/150 (9.3%) cats, leukocytosis (WBC >14,390/μL) in 5/150 
(3.3%) cats, and thrombocytopenia (PLT <200,670/μL) in 10/150 (6.7%) cats 
(Moritz et al, 2004). Surplus blood was stored at -20°C and used for PCR assay. 
Sera separated from whole blood were tested for antibodies to FIV (gp40 and 
p24 FIV antigens; n=166) and FeLV p27 antigen (n=166) using a commercial 
ELISA kit (Snap FeLV/FIV Combo Plus Test, Idexx Laboratories, Hoofddorp, 
Netherlands). Thirteen (7.8%) cats tested positive for FIV and 6 (3.6%) were 
positive for FeLV. The presence of IgG antibodies against Toxoplasma gondii 
was evaluated using a commercial indirect fluorescent antibody test (IFAT) kit 
(Fuller Laboratories, Fullerton, CA, USA). An antibody titer ≥1:64 was 
considered indicative of T. gondii exposure (Dubey and Lappin 2012) and was 
detected in 31/113 (27.4%) cases. 
 
PCR assay  
 Conventional PCR was performed on blood samples to amplify pathogen-
associated DNA associated with hemoplasmas (M. haemofelis - Mhf and M. 
haemominutum – Mhm), Rickettsia spp, A. phagocytophilum, Ehrlichia spp. and 
B. microti. The reaction mixture included 2 μl of template DNA, 0.25 mM 
dNTPs, 0.4 mM of each primer, 1X reaction buffer and 2.5 U Tap DNA 
polymerase (GoTaq® DNA Polymerase, Promega, Madison, WI USA). The 
volume of this mixture was adjusted to 25 μl with sterile water. Primer names, 
sequences and amplicon size (bp) are summarized in Table 1 and PCR 
conditions have been previously reported (Tzianabos et al 1989; Persing et al 
1992; Munderloh et al 1996; Jensen et al 2001; de la Fuente et al 2005). PCR 
reactions were performed using an automated thermocycler. PCR products were 
resolved using 1% agarose gels and fragment size was estimated using a DNA 
molecular weight marker (1Kb DNA Ladder; Promega Madison, WI USA). 
Control reactions were done in the absence of template DNA to rule out 
contaminations during PCR.  
 
Statistical analysis  
 The prevalence of each pathogen was calculated and reported as the 
percent of cats with a positive test result. Univariate analysis of categorical data 
was performed using the chi-square test (cell frequencies of >5) or Fisher’s exact 
test (cell frequencies of ≤5). Any parameters statistically linked to positive PCR 
results were used in a logistic regression model to test for independent risk 
factors associated with infection. Associations were considered statistically 
significant when P<0.05. Both the P value and odds ratio (OR) with 95% 
confidence interval (CI) are reported. Data were analyzed using MedCalc 
Software (version 12.3.0; Mariakerke, Belgium). 
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Results  
 Overall, DNA of one or more pathogen was detected in 60% (156/260) 
of blood samples tested. Of the positive samples, 102/156 cases were infected 
with only one pathogen and 54/156 (34.6%) contained multiple pathogens 
(Table 2). Specifically, 46/156 cases (29.5%) were positive for two pathogens 
and 8/156 (5.2%) samples contained three pathogens.  
 Statistical association between pathogen-positive samples and risk factors 
are shown in Table 3. There were no correlations between colony location, age, 
gender, BCS, CBC abnormalities, FIV, FeLV, T. gondii status and vector-borne 
infections. Variables linked to PCR-positive results were co-infection between 
hemoplasmas and Rickettsia spp (OD=1.95, P=0.02, 95%CI=1.13-3.35). 
Moreover, the presence of ocular infections is associated with Rickettsia spp. 
infection (OR=2.21, P=0.02, 95%CI=1.11-4.38).  
 The prevalence of Babesia spp. and Ehrlichia spp. was low (1.2% and 
6.7%, respectively), thus statistical investigation of these pathogens was not 
performed. Data from these pathogens was available in only 168 and 30 samples 
respectively because the limited blood was not enough for completion of the 
analysis. 
 
Discussion 
 We present the first study investigating the prevalence of FVBDs in urban 
feral colony cats from the city of Milan. It is difficult to assess the overall 
prevalence of feline infection by different pathogens due to the limited amount 
of available data, difficulties in comparing information from studies using 
different diagnostic tools (i.e. molecular and serological) and confounding 
factors associated with distinct study populations (i.e. feral and domestic cats).  
To our knowledge there is only one study on the prevalence of hemoplasmas in 
domestic cats (Gentilini et al, 2009). This study was performed at a veterinary 
teaching hospital in northern Italy and reported positive PCRs (nested) in 18.9% 
of domestic cats. The authors found that hemoplasma PCR-positive status was 
not significantly associated with anemia, which is consistent with our results 
here. This discrepancy could be explained by the stage of infection or the higher 
prevalence of M. haemominutum (Mhm), a less pathogenic species than M. 
haemofelis (Mhf). In the study of Gentilini et al., the prevalence of Mhm and 
Mhf was 17.3% and 5.9%, respectively. However, in our study Mhm was not 
differentiated from Mhf.    
The prevalence of hemoplasmas in feral cats was higher in our study (33.1%) 
compared to other studies worldwide: 20.5% in Florida (Luria et al, 2004), 12.5% 
in Arizona (Eberhardt et al, 2006), and 13.3% in Ireland (Juvet et al, 2010). A 
study from Ontario reported a 47% prevalence of Mhf, although that was 
determined from a small sampling (n=45) of stray cats (Kamrani et al, 2008).  
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 High incidence of hemoplasmas in stray cats is not surprising as outdoor 
access is a recognized risk factor for infection. For example, in a study of 191 
domestic cats from Barcelona (Spain), hemoplasmas were detected in 12% of 
cases and outdoor access was found to be a risk factor for infection (OR=3.8) 
(Roura et al, 2010). Additionally, in a study involving feline blood donors from 
the USA, the prevalence of hemoplasmas was 19.7% in domestic cats with 
outdoor access, and only 3.6% in domestic cats not allowed outdoors (Hackett et 
al, 2006). The higher incidence of hemoplasmas in domestic cats that are allowed 
outdoors and in cats with a pre-existing vector-borne infections, as observed in 
our study with Rickettsia spp. (OD=1.95, P=0.02), support the suggestion that 
ticks and fleas could be responsible for transmitting these diseases, as previously 
reported  (Willi et al 2007).  
With the exception of Rickettsia acari and Rickesstia felis, which are transmitted 
by mites and fleas respectively, ticks are the main vectors for Rickettia spp. 
(Greene, Kidd and Breitschwerd 2012). Rickettsia spp. were detected in 13-
15.7% of ticks collected from public parks in northern Italy (Corrain et al, 2012; 
Capelli et al, 2012). Recent studies have revealed high levels of R. felis 
(responsible for flea-borne spotted fever in humans) in fleas (Ctenocephalides 
felis and Ctenocephalides canis) collected from house and stray cats from north-
eastern Italy (Capelli et al 2009). Despite their presence in arthropod vectors, 
Rickettsia infections in cats are generally low worldwide. We detected an 
association between PCR positive cats for Rickettsia spp. and the presence of 
ocular infection (OR=2.2, P=0.02). In dogs, Rickettsia infection can cause ocular 
abnormalities (Greene, Kidd and Breitschwerd 2012) and, although not 
documented, we suggest the same could occur in felines.  
Human granulocytic anaplasmosis, caused by rickettsial bacteria, occurs in 6% of 
patients living in northern Italy with a history of tick bites (Beltrame et al, 2006). 
The prevalence of the bacteria in the vector tick, Ixodes ricinus, is between 1.5% 
(Capelli et al 2012) to 9.2% in northern Italy (Aureli et al, 2012).   
 In the United Kingdom, various rodent species have been shown to 
harbor A. phagocytophilum  (Bown et al, 2003). DNA associated with A. 
phagocytophilum has been detected in naturally infected domestic cats from 
Finland (Heikkila et al, 2010), the United Kingdom (Shaw et al, 2005), and Italy 
(Tarello 2005). In our study, 17.7% of cats were infected with A. 
phagocytophilum, which is higher than other studies worldwide. These studies 
were performed in domestic cats from eastern Australia (Barrs et al 2010), 
domestic cats from the USA (Lappin et al 2006), blood donor cats from the USA 
(Hackett et al, 2006), and feral cats from northern Florida (Luria et al, 2004), 
Arizona (Eberhardt et al, 2006) and Ireland (Juvet et al, 2010). In some cases, A. 
phagocytophilum DNA was not detected by PCR in seropositive cats (mainly 
86 
 
IFAT) from the USA (Billeter et al, 2007), and Spain (Solano-Gallego et al, 2006, 
Aguirre et al, 2004). 
 The prevalence of Ehrlichia in our study group (n=30) was 6.7%. 
Ehrlichia spp. that infect cats have been not fully determined (Lappin and 
Breitschwerdt 2012). The majority of epidemiological data on Ehrlichia spp. 
infection in cats are based on serological surveys. To the best of our knowledge, 
only two studies address Ehrlichia prevalence in Italy. One study serologically 
detected Ehrlichia in 10.2% of stray cats from shelters in Tuscany (Ebani and 
Andreani 2002). Another study from the Abruzzo region detected two 
seropositive cats out of 203, although both were PCR-negative (Vita et al, 2005). 
A study from Spain found that only one out of 100 cats was positive for 
Ehrlichia spp. (Tabar et al, 2008). In central and northeastern Spain, despite 
seroprevalence of 10.6% (Aguirre et al, 2004) and 11.3% (Solano-Gallego 2006) 
respectively, no Ehrlichia-associated DNA was amplified by PCR. Similarly, the 
pathogen was not amplified 146 blood donor cats in USA (Hackett et al, 2006).  
The first confirmed autochthonous case of human B. microti infection in 
Europe was recently reported (Hildebrandt et al, 2007) and followed by a study 
that isolated B. microti in ticks (Ixodes ricinus) removed from dogs and cats 
(Lempereur at al 2011). Moreover, a recent study reported the presence of 
zoonotic B. microti in rodents from Croatia (Beck et al, 2010). Information on 
the prevalence of this pathogen in the feline population worldwide is limited. We 
detected a low prevalence (1.2%), which is in agreement with the value (1.4%) in 
stray cats from Thailand (Simking et al, 2010). Babesia species were not detected 
in domestic cats from Spain (Tabar et al, 2008). 
These results are particularity important in cases where blood transfusions are 
used for treatment of cats. Because FVBDs infections usually precede overt 
symptoms, donated blood may harbor vector-borne pathogens. Additionally, 
feline hemoplasmas were demonstrated to be transmitted by blood (Gary et al, 
2006) and possibly Ehrlichia spp., A. phagocytophilum and Rickettia spp. 
(Lappin and Breitschwerd 2012; Lappin and Breitschwerd 2012) can be 
transmitted through blood. Thus, feline blood donors should be tested for 
pathogens in regions where these infections are prevalent, as suggested by 
American College of Veterinary Internal Medicine Consensus Statement 
(Wardrop et al 2005). 
This study had certain limitations considering information on the differentiation 
of hemoplasmas (Mhf versus Mhm) in our study population was lacking. Each 
type of hemoplasma has unique prognostic concerns, as their pathogenicity 
varies from being asympthomatic (e.g. MHM) to hemolytic anemia (e.g. MHF) 
(Messick and Harvey 2012). Moreover, some pathogens have been investigated 
only at the genus level (e.g. Rickettsia spp. and Ehrlichia spp.) and we lacked 
information about the species that infected our population. Ectoparasitism was 
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not investigated and, consequently, we did not identify potential vectors 
associated with the pathogens in this study. Regardless of these limitations, we 
believe that this study provides new and useful information on feline vector-
borne infections in Italy.  
In conclusion, we found that vector-borne infections were present in the feral 
feline population of Milan. Indeed, pet cats with outdoor access in this region 
should be regularly monitored and treated for ectoparasites to minimize health 
risks to humans and pets. Importantly, feline blood donors in northern Italy 
should be screened with PCR for these emerging infections.  
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Table 1. The names, sequences and amplicon size (bp) of PCR primers used in this study 
 
 
 
Organism  
detected   
Primer  
name Nucleotide sequence (5'-3') Amplicon size (bp) 
Reference  
Rickettsia spp 
Tz-15-19  TTCTCAATTCGGTAAGGGC  
246 
Tzianabos et 
al 1989 
Tz-16-20  ATATTGACCAGTGCTATTTC 
Babesia  
microti 
BAB1 CTTAGTATAAGCTTTTATACAGC 
238 
Persing et al, 
1992 
BAB4 ATAGGTCAGAAACTTGAATGATACA  
Ehrlichia spp 
PER1 TTTATCGCTATTAGATGAGCCTATG  
451 
Munderloh et 
al, 1996 
PER2 CTCTACACTAGGAATTCCGCTAT  
Hemoplasmas  
(Mycoplasma  
heamofelis and  
Mycoplasma  
haemominutum)  
 
fHf   ACGAAAGTCTGATGGAGCAATA 
170-193 
Jensen et al, 
2001 
rHf  ACGCCCAATAAATCCG(A/G)ATAAT 
Anaplasma  
phagocytophilum 
MSP4AP5 ATGAATTACAGAGAATTGCTTGTAGG 
849 
de la Fuente 
et al, 2005 
MSP4AP3 TTAATTGAAAGCAAATCTTGCTCCTATC 
89 
 
 
Table 2. The prevalence of vector-borne infections in feral colony cats based on 
PCR detection of bacterial DNA. 
 
 
Vector-borne pathogen  
(number of cats tested for) 
Number  
of infected  
cats 
Observed  
prevalence  
(%) 
95%CI 
Hemoplasmas  (n=260) 86 33.1 26.5-40.9 
Rickettsia spp. (n=260) 83 31.9 25.4-39.6 
Anaplasma phagocytophilum (n=260) 46 17.7 13.0-23.6 
Ehrlichia spp. (n=30) 2 6.7 0.8-24.1 
Babesia microtii (n=168) 2 1.2 0.1-4.3 
Hemoplasmas + Rickettsia spp 29 11.1 7.5-16.0 
Hemoplasmas + A. phagocytophilum  9 3.5 1.6-6.6 
A. phagocytophilum  + Rickettsia spp 6 2.3 0.8-5.0 
Rickettsia spp + Ehrlichia spp 2 0.8 0.1-2.8 
Hemoplasmas + A. phagocytophilum  + 
Rickettsia spp 
7 2.7 1.1-5.5 
Hemoplasmas + A. phagocytophilum  + B. 
microtii 
1 0.4 0.01-2.1 
 
 
 
Table 3. The prevalence of hemoplasma, Rickettsia spp., and A. 
phagocytophilum in feral colony cats based on PCR detection of bacterial DNA 
 
 
 
Factor 
  
Categor
y 
  
Hemopla
smaposit
ive 
number 
(%) 
P value  
  
A. 
phagocytophilu
m positive 
number (%) 
P value  
  
Rickettsi
a spp. 
positive 
number 
(%) 
P value  
  
Origin  
of the  
cats 
zone 1 
0/86 
(0.0) P=0.54 0/46 (0.0) P=0.96 
1/83 
(1.2) P=0.57 
zone 2 
5/86 
(5.8) P=0.57 3/46 (6.5) P=0.66 
3/83 
(3.6) P=0.99 
zone 4  
40/86 
(46.5) P=0.31 24/46 (52.2) P=0.15 
41/83 
(49.4) P=0.10 
zone 5  
4/86 
(4.7) P=0.77 0/46 (0.0) P=0.21 
2/83 
(2.4) P=0.40 
zone 6 
12/86 
(14.0) P=0.27 0/46 (0.0) P=0.18 
4/83 
(4.8) P=0.07 
zone 7 
14/86 
(16.3) P=0.23 15/46 (32.6) P=0.06 
19/83 
(22.9) P=0.76 
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zone 8 8/86 (9.3) P=0.92 0/46 (0.0) P=0.05 
9/83 
(10.8) P=0.48 
zone 9 
3/86 
(3.5) P=0.07 4/46 (8.7) P=0.82 
4/83 
(4.8) P=0.23 
Age Juvenile           
(≤ 6 
months) 
37/86 
(43.0) P=0.69 21/46 (45.7) P=0.90 
42/83 
(50.6) P=0.31 
Adult              
(>6 
months) 
49/86 
(57.0)  25/46 (54.3) 
41/83 
(49.4) 
Gender 
Male 
60/86 
(69.8) P=0.37 14/46 (30.4) P=0.63 
22/83 
(26.5) P=0.08 
Female 
26/86 
(30.2) 32/46 (69.6) 
61/83 
(79.5) 
BCS Poor (1-
3/9)  
8/78 
(10.3) P=0.37 1/44 (2.3) P=0.26 
5/83 
(6.0) P=0.74 
Good (4-
6/9) 
70/78 
(89.7) 43/44 (97.7) 
78/83 
(94.0) 
Health 
status Healthy 
25/86 
(29.1) P=0.84 18/46 (39.1) P=0.08 
24/83 
(28.9) P=0.88 
Unhealth
y 
61/86 
(70.9) 28/46 (60.9) 
59/83 
(71.1) 
Clinical 
abnormal
ities in 
unhealth
y cats 
Lymph 
node 
enlargem
ent 
46/86 
(53.5) P=0.69 21/46 (45.7) P=0.51 
45/83 
(54.2) P=0.59 
Pale 
mucous 
membran
es  
3/86 
(3.5) P=0.51 4/46 (8.7) P=0.46 
1/83 
(1.2) P=0.08 
Stomatiti
s 
30/86 
(34.9) P=0.43 14/46 (30.4) P=0.26 
25/83 
(30.1) P=0.07 
Signs of 
respirator
y tract 
infection 
10/86 
(11.6) P=0.29 3/46 (6.5) P=0.82 
9/83 
(10.8) P=0.48 
Signs of 
ocular 
infection 
14/86 
(16.3) P=0.92 7/46 (15.2) P=0.85 
19/83 
(22.9) 
OR=2.21  
CI=1.11- 
4.38 
P=0.02 
CBC 
abnormal
ities 
  
Anaemia 
29/59 
(49.2) P=0.69 17/37 (45.9) P=0.89 
35/71 
(49.3) P=0.59 
Leukope
nia 
4/59 
(6.8) P=0.56 2/37 (5.4) P=0.53 
5/71 
(7.0) P=0.53 
Leukocyt
osis 
2/59 
(3.4) P=0.66 3/37 (8.1) P=0.18 
2/71 
(2.8) P=0.90 
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Thrombo
cytopenia 
6/59 
(10.2) P=0.30 3/37 (8.1) P=0.99 
6/71 
(8.5) P=0.63 
Hemopla
smas 
PCR 
results 
Positive  
- - 18/46 (39.1) P=0.43 
36/83 
(43.4) 
OR=1.95  
CI=1.13-
3.35 
P=0.02 
Negative  
- - 28/46 (60.9)  
47/83 
(56.6) 
A. 
phagocyt
ophilum  
PCR 
results 
Positive 
18/86 
(20.9) P=0.43 - - 
14/83 
(16.9) 
Negative 
68/86 
(79.1) - - 
69/83 
(83.1) 
Rickettsi
a spp. 
PCR 
results 
Positive 
36/86 
(41.9) 
OR=1.9
5  
CI= 
1.13-
3.35 
P=0.02 
14/46 (30.4) 
P=0.95 
- 
- Negative 
50/86 
(58.1) 32/46 (69.6) - 
B. 
microti 
PCR 
results 
Positive  
1/63 
(1.6) 
P=0.71 
1/42 (2.4) 
P=1.00 
0/83 
(0.0) 
P=0.49 Negative 
62/63 
(98.4) 41/42 (97.6) 
83/83 
(100) 
Ehrlichia 
spp. PCR 
results 
Positive  
0/13 
(0.0) 
P=0.59 
0/5 (0.0) 
P=0.74 
2/12 
(16.7) 
P=0.30 Negative 
13/13 
(100) 5/5 (100) 
10/12 
(83.3) 
FIV test 
results Positive 
5/64 
(7.8) 
P=0.82 
5/39 (12.8) 
P=0.35 
5/78 
(6.4) 
P=0.68 Negative 
59/64 
(92.2) 34/39 (87.2) 
73/78 
(93.6) 
FeLV 
test 
results 
Positive 
2/64 
(3.1) 
P=0.90 
0/39 (0.0) 
P=0.36 
2/78 
(2.6) 
P=0.75 Negative 
62/64 
(96.9) 39/39 (100) 
76/78 
(97.4) 
T. gondii 
test 
results 
Positive 
13/46 
(28.3) 
P=0.92 
6/23 (26.1) 
P=0.94 
18/65 
(27.7) 
P=0.83 Negative 
33/46 
(71.7) 17/23 (73.9) 
47/65 
(72.3) 
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